Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Chiu, M. Armstrong, E.J. Jennings, V. Foo, S. Crespo-Rodriguez, E. Bozhanova, G. Patin, E.C. McLaughlin, M. Mansfield, D. Baker, G. Grove, L. Pedersen, M. Kyula, J. Roulstone, V. Wilkins, A. McDonald, F. Harrington, K. Melcher, A. (2020). Combination therapy with oncolytic viruses and immune checkpoint inhibitors. Expert opinion on biological therapy, Vol.20 (6), pp. 635-652.

Rodriguez-Ruiz, M.E. Vitale, I. Harrington, K.J. Melero, I. Galluzzi, L. (2020). Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nature immunology, Vol.21 (2), pp. 120-134.

Gurney‐Champion, O.J. Rauh, S.S. Harrington, K. Oelfke, U. Laun, F.B. Wetscherek, A. (2020). Optimal acquisition scheme for flow‐compensated intravoxel incoherent motion diffusion‐weighted imaging in the abdomen: An accurate and precise clinically feasible protocol. Magnetic resonance in medicine, Vol.83 (3), pp. 1003-1015.

Grünwald, V. Chirovsky, D. Cheung, W.Y. Bertolini, F. Ahn, M.-. Yang, M.-. Castro, G. Berrocal, A. Sjoquist, K. Kuyas, H. Auclair, V. Guillaume, X. Joo, S. Shah, R. Harrington, K. (2020). Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study. Oral oncology, Vol.102, pp. 104526-104526.

Haddad, R. Cohen, E.E. Venkatachalam, M. Young, K. Singh, P. Shaw, J.W. Korytowsky, B. Abraham, P. Harrington, K.J. (2020). Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States. Journal of medical economics, Vol.23 (5), pp. 442-447.

McLaughlin, M. Patin, E.C. Pedersen, M. Wilkins, A. Dillon, M.T. Melcher, A.A. Harrington, K.J. (2020). Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nature reviews cancer, Vol.20 (4), pp. 203-217.

Hardman, J. Liu, Z. Brady, G. Roe, J. Kerawala, C. Riva, F. Clarke, P. Kim, D. Bhide, S. Nutting, C. Harrington, K. Paleri, V. (2020). Transoral robotic surgery for recurrent cancers of the upper aerodigestive tract—Systematic review and meta‐analysis. Head & neck, Vol.42 (5), pp. 1089-1104.

Driscoll, C.B. Schuelke, M.R. Kottke, T. Thompson, J.M. Wongthida, P. Tonne, J.M. Huff, A.L. Miller, A. Shim, K.G. Molan, A. Wetmore, C. Selby, P. Samson, A. Harrington, K. Pandha, H. Melcher, A. Pulido, J.S. Harris, R. Evgin, L. Vile, R.G. (2020). APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nature communications, Vol.11 (1).

Mehanna, H. Robinson, M. Hartley, A. Kong, A. Foran, B. Fulton-Lieuw, T. Dalby, M. Mistry, P. Sen, M. O'Toole, L. Al Booz, H. Dyker, K. Moleron, R. Whitaker, S. Brennan, S. Cook, A. Griffin, M. Aynsley, E. Rolles, M. De Winton, E. Chan, A. Srinivasan, D. Nixon, I. Grumett, J. Leemans, C.R. Buter, J. Henderson, J. Harrington, K. McConkey, C. Gray, A. Dunn, J. Moleron, R. McArdle, O. Dyker, K. Al Booz, H. O'Toole, L. Cook, A. Husband, D. Loo, V. Soe, W. Aynsley, E. Sridhar, T. Jankowska, P. Joseph, M. Geropantas, K. Vaidya, D. Griffin, M. Hartley, A. Vijayan, R. Hwang, D. Harrington, K. Pettit, L. Whitaker, S. De Winton, E. Rolles, M. Brennan, S. Sen, M. Mendes, R. Forster, M. Chan, A. Evans, M. Buter, J. Srinivasan, D. Foran, B. Nankivell, P. Bryant, J. Sharma, N. Spruce, R. Brooks, J. Batis, N. Roques, T. Bidmead, M. Yang, H. Nutting, C. Tyler, J. Henderson, J. Baines, H. Gasnier, A. Miles, E. Clark, C. Evans, M. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. The lancet, Vol.393 (10166), pp. 51-60.

Cohen, E.E. Soulières, D. Le Tourneau, C. Dinis, J. Licitra, L. Ahn, M.-. Soria, A. Machiels, J.-. Mach, N. Mehra, R. Burtness, B. Zhang, P. Cheng, J. Swaby, R.F. Harrington, K.J. Acosta-Rivera, M. Adkins, D.R. Aghmesheh, M. Ahn, M.-. Airoldi, M. Aleknavicius, E. Al-Farhat, Y. Algazi, A.P. Almokadem, S. Alyasova, A. Bauman, J.R. Benasso, M. Berrocal, A. Bray, V. Burtness, B.A. Caponigro, F. Castro, A. Cescon, T.P. Chan, K. Chaudhry, A. Chauffert, B. Cohen, E. Csoszi, T. De Boer, J.P. Delord, J.-. Dietz, A. Dinis, J. Dupuis, C. Digue, L. Erfan, J. Escobar Alvarez, Y. Evans, M. Fidler, M.J. Forster, M.D. Friesland, S. Ganti, A.K. Geoffrois, L. Grant, C. Gruenwald, V. Harrington, K. Hoffmann, T. Horvai, G. Inciura, A. Jang, R. Jankowska, P. Jimeno, A. Joseph, M. Juarez Ramiro, A. Karaszewska, B. Kawecki, A. Keilholz, U. Keller, U. Kim, S.-. Kocsis, J. Kotecki, N. Kozloff, M.F. Lambea, J. Landherr, L. Lantsukhay, Y. Lazarev, S.A. Lee, L.W. Le Tourneau, C. Licitra, L. Lifirenko, I.D. Mach, N. Martincic, D. Matorin, O.V. McGrath, M. Machiels, J.-. Mehra, R. Misiukiewicz, K. Morris, J.C. Mufazalov, F.F. Niu, J. Pamoorthy Srinivasan, D. Perez Segura, P. Rauch, D. Ribeiro, M.L. Rodriguez, C. Rolland, F. Russo, A. Ruzsa, A. Sanches, F. Shin, S.-. Shtiveland, M. Soulieres, D. Soria, A. Specenier, P. Szekanecz, E. Szota, J. van Herpen, C.M. Velez-Cortes, H.A. Walsh, W.V. Wilop, S. Winterhalder, R. Wojtukiewicz, M. Wong, D. Zandberg, D. (2019). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. The lancet, Vol.393 (10167), pp. 156-167.

Smith, H.G. Mansfield, D. Roulstone, V. Kyula-Currie, J.N. McLaughlin, M. Patel, R.R. Bergerhoff, K.F. Paget, J.T. Dillon, M.T. Khan, A. Melcher, A. Thway, K. Harrington, K.J. Hayes, A.J. (2019). PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma. Clinical cancer research, Vol.25 (11), pp. 3443-3454.

Annels, N.E. Mansfield, D. Arif, M. Ballesteros-Merino, C. Simpson, G.R. Denyer, M. Sandhu, S.S. Melcher, A.A. Harrington, K.J. Davies, B. Au, G. Grose, M. Bagwan, I. Fox, B. Vile, R. Mostafid, H. Shafren, D. Pandha, H.S. (2019). Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer. Clinical cancer research, Vol.25 (19), pp. 5818-5831.

Ferris, R.L. Licitra, L. Fayette, J. Even, C. Blumenschein, G. Harrington, K.J. Guigay, J. Vokes, E.E. Saba, N.F. Haddad, R. Ramkumar, S. Russell, J. Brossart, P. Tahara, M. Colevas, A.D. Concha-Benavente, F. Lynch, M. Li, L. Gillison, M.L. (2019). Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clinical cancer research, Vol.25 (17), pp. 5221-5230.

Burtness, B. Haddad, R. Dinis, J. Trigo, J. Yokota, T. de Souza Viana, L. Romanov, I. Vermorken, J. Bourhis, J. Tahara, M. Martins Segalla, J.G. Psyrri, A. Vasilevskaya, I. Nangia, C.S. Chaves-Conde, M. Kiyota, N. Homma, A. Holeckova, P. Del Campo, J.M. Asarawala, N. Nicolau, U.R. Rauch, D. Even, C. Wang, B. Gibson, N. Ehrnrooth, E. Harrington, K. Cohen, E.E. (2019). Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck. Jama oncology, Vol.5 (8), pp. 1170-1170.

Harrington, K.J. (2019). Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RT. Clinical cancer research, Vol.25 (1), pp. 3-5.

Burley, T.A. Da Pieve, C. Martins, C.D. Ciobota, D.M. Allott, L. Oyen, W.J. Harrington, K.J. Smith, G. Kramer-Marek, G. (2019). Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. Journal of nuclear medicine, Vol.60 (3), pp. 353-361.

Wilkins, A.C. Patin, E.C. Harrington, K.J. Melcher, A.A. (2019). The immunological consequences of radiation‐induced DNA damage. The journal of pathology, Vol.247 (5), pp. 606-614.

Evgin, L. Huff, A.L. Kottke, T. Thompson, J. Molan, A.M. Driscoll, C.B. Schuelke, M. Shim, K.G. Wongthida, P. Ilett, E.J. Smith, K.K. Harris, R.S. Coffey, M. Pulido, J.S. Pandha, H. Selby, P.J. Harrington, K.J. Melcher, A. Vile, R.G. (2019). Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment. Cancer immunology research, Vol.7 (5), pp. 828-840.

Jennings, V.A. Scott, G.B. Rose, A.M. Scott, K.J. Migneco, G. Keller, B. Reilly, K. Donnelly, O. Peach, H. Dewar, D. Harrington, K.J. Pandha, H. Samson, A. Vile, R.G. Melcher, A.A. Errington-Mais, F. (2019). Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular therapy, Vol.27 (6), pp. 1139-1152.

Saba, N.F. Blumenschein, G. Guigay, J. Licitra, L. Fayette, J. Harrington, K.J. Kiyota, N. Gillison, M.L. Ferris, R.L. Jayaprakash, V. Li, L. Brossart, P. (2019). Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age. Oral oncology, Vol.96, pp. 7-14.

Gurney-Champion, O.J. Collins, D.J. Wetscherek, A. Rata, M. Klaassen, R. van Laarhoven, H.W. Harrington, K.J. Oelfke, U. Orton, M.R. (2019). Principal component analysis for fast and model-free denoising of multi b-value diffusion-weighted MR images. Phys med biol, .  show abstract

Hall, W.A. Paulson, E.S. van der Heide, U.A. Fuller, C.D. Raaymakers, B.W. Lagendijk, J.J. Li, X.A. Jaffray, D.A. Dawson, L.A. Erickson, B. Verheij, M. Harrington, K.J. Sahgal, A. Lee, P. Parikh, P.J. Bassetti, M.F. Robinson, C.G. Minsky, B.D. Choudhury, A. Tersteeg, R.J. Schultz, C.J. (2019). The transformation of radiation oncology using real-time magnetic resonance guidance: A review. European journal of cancer, Vol.122, pp. 42-52.

Lee, A.W. Ng, W.T. Pan, J.J. Chiang, C.-. Poh, S.S. Choi, H.C. Ahn, Y.C. AlHussain, H. Corry, J. Grau, C. Grégoire, V. Harrington, K.J. Hu, C.S. Kwong, D.L. Langendijk, J.A. Le, Q.T. Lee, N.Y. Lin, J.C. Lu, T.X. Mendenhall, W.M. O'Sullivan, B. Ozyar, E. Peters, L.J. Rosenthal, D.I. Sanguineti, G. Soong, Y.L. Tao, Y. Yom, S.S. Wee, J.T. (2019). International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. International journal of radiation oncology*biology*physics, Vol.105 (3), pp. 567-580.

Burtness, B. Harrington, K.J. Greil, R. Soulières, D. Tahara, M. de Castro, G. Psyrri, A. Basté, N. Neupane, P. Bratland, Å. Fuereder, T. Hughes, B.G. Mesía, R. Ngamphaiboon, N. Rordorf, T. Wan Ishak, W.Z. Hong, R.-. González Mendoza, R. Roy, A. Zhang, Y. Gumuscu, B. Cheng, J.D. Jin, F. Rischin, D. Lerzo, G. Tatangelo, M. Varela, M. Zarba, J.J. Boyer, M. Gan, H. Gao, B. Hughes, B. Mallesara, G. Rischin, D. Taylor, A. Burian, M. Fuereder, T. Greil, R. Barrios, C.H. de Castro Junior, D.O. Castro, G. Franke, F.A. Girotto, G. Lima, I.P. Nicolau, U.R. Pinto, G.D. Santos, L. Victorino, A.-. Chua, N. Couture, F. Gregg, R. Hansen, A. Hilton, J. McCarthy, J. Soulieres, D. Ascui, R. Gonzalez, P. Villanueva, L. Torregroza, M. Zambrano, A. Holeckova, P. Kral, Z. Melichar, B. Prausova, J. Vosmik, M. Andersen, M. Gyldenkerne, N. Jurgens, H. Putnik, K. Reinikainen, P. Gruenwald, V. Laban, S. Aravantinos, G. Boukovinas, I. Georgoulias, V. Psyrri, A. Kwong, D. Al-Farhat, Y. Csoszi, T. Erfan, J. Horvai, G. Landherr, L. Remenar, E. Ruzsa, A. Szota, J. Billan, S. Gluck, I. Gutfeld, O. Popovtzer, A. Benasso, M. Bui, S. Ferrari, V. Licitra, L. Nole, F. Fujii, T. Fujimoto, Y. Hanai, N. Hara, H. Matsumoto, K. Mitsugi, K. Monden, N. Nakayama, M. Okami, K. Oridate, N. Shiga, K. Shimizu, Y. Sugasawa, M. Tahara, M. Takahashi, M. Takahashi, S. Tanaka, K. Ueda, T. Yamaguchi, H. Yamazaki, T. Yasumatsu, R. Yokota, T. Yoshizaki, T. Kudaba, I. Stara, Z. Wan Ishak, W.Z. Cheah, S.K. Aguilar Ponce, J. Gonzalez Mendoza, R. Hernandez Hernandez, C. Medina Soto, F. Buter, J. Hoeben, A. Oosting, S. Suijkerbuijk, K. Bratland, A. Brydoey, M. Alvarez, R. Mas, L. Caguioa, P. Querol, J. Regala, E.E. Tamayo, M.B. Villegas, E.M. Kawecki, A. Karpenko, A. Klochikhin, A. Smolin, A. Zarubenkov, O. Goh, B.C. Cohen, G. du Toit, J. Jordaan, C. Landers, G. Ruff, P. Szpak, W. Tabane, N. Brana, I. Iglesias Docampo, L. Lavernia, J. Mesia, R. Abel, E. Muratidu, V. Nielsen, N. Cristina, V. Rordorf, T. Rothschild, S. Hong, R.-. Wang, H.-. Yang, M.-. Yeh, S.-. Yen, C.-. Ngamphaiboon, N. Soparattanapaisarn, N. Sriuranpong, V. Aksoy, S. Cicin, I. Ekenel, M. Harputluoglu, H. Ozyilkan, O. Harrington, K. Agarwala, S. Ali, H. Alter, R. Anderson, D. Bruce, J. Burtness, B. Campbell, N. Conde, M. Deeken, J. Edenfield, W. Feldman, L. Gaughan, E. Goueli, B. Halmos, B. Hegde, U. Hunis, B. Jotte, R. Karnad, A. Khan, S. Laudi, N. Laux, D. Martincic, D. McCune, S. McGaughey, D. Misiukiewicz, K. Mulford, D. Nadler, E. Neupane, P. Nunnink, J. Ohr, J. O'Malley, M. Patson, B. Paul, D. Popa, E. Powell, S. Redman, R. Rella, V. Rocha Lima, C. Sivapiragasam, A. Su, Y. Sukari, A. Wong, S. Yilmaz, E. Yorio, J. (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. The lancet, Vol.394 (10212), pp. 1915-1928.

Wilkins, A. McDonald, F. Harrington, K. Melcher, A. (2019). Radiotherapy enhances responses of lung cancer to CTLA-4 blockade. Journal for immunotherapy of cancer, Vol.7 (1).

Thomas, S. Kuncheria, L. Roulstone, V. Kyula, J.N. Mansfield, D. Bommareddy, P.K. Smith, H. Kaufman, H.L. Harrington, K.J. Coffin, R.S. (2019). Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1. Journal for immunotherapy of cancer, Vol.7 (1).

Andtbacka, R.H. Collichio, F. Harrington, K.J. Middleton, M.R. Downey, G. Ӧhrling, K. Kaufman, H.L. (2019). Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma. Journal for immunotherapy of cancer, Vol.7 (1).

Müller, L.M. Holmes, M. Michael, J.L. Scott, G.B. West, E.J. Scott, K.J. Parrish, C. Hall, K. Stäble, S. Jennings, V.A. Cullen, M. McConnell, S. Langton, C. Tidswell, E.L. Shafren, D. Samson, A. Harrington, K.J. Pandha, H. Ralph, C. Kelly, R.J. Cook, G. Melcher, A.A. Errington-Mais, F. (2019). Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21. Journal for immunotherapy of cancer, Vol.7 (1).

Forster, M.D. Dillon, M.T. Kocsis, J. Remenár, É. Pajkos, G. Rolland, F. Greenberg, J. Harrington, K.J. (2019). Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study. European journal of cancer, Vol.123, pp. 36-47.

Dillon, M.T. Grove, L. Newbold, K.L. Shaw, H. Brown, N.F. Mendell, J. Chen, S. Beckman, R.A. Jennings, A. Ricamara, M. Greenberg, J. Forster, M. Harrington, K.J. (2019). Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study. Clinical cancer research, Vol.25 (2), pp. 487-495.

Haddad, R. Concha‐Benavente, F. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Kasper, S. Vokes, E.E. Worden, F. Saba, N.F. Tahara, M. Jayaprakash, V. Lynch, M. Li, L. Gillison, M.L. Harrington, K.J. Ferris, R.L. (2019). Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Cancer, Vol.125 (18), pp. 3208-3218.

Lee, A.W. Ng, W.T. Pan, J.J. Poh, S.S. Ahn, Y.C. AlHussain, H. Corry, J. Grau, C. Grégoire, V. Harrington, K.J. Hu, C.S. Kwong, D.L. Langendijk, J.A. Le, Q.T. Lee, N.Y. Lin, J.C. Lu, T.X. Mendenhall, W.M. O'Sullivan, B. Ozyar, E. Peters, L.J. Rosenthal, D.I. Soong, Y.L. Tao, Y. Yom, S.S. Wee, J.T. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and oncology, Vol.126 (1), pp. 25-36.

Dean, J. Wong, K. Gay, H. Welsh, L. Jones, A.-. Schick, U. Oh, J.H. Apte, A. Newbold, K. Bhide, S. Harrington, K. Deasy, J. Nutting, C. Gulliford, S. (2018). Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. Clinical and translational radiation oncology, Vol.8, pp. 27-39.

Burley, T.A. Mączyńska, J. Shah, A. Szopa, W. Harrington, K.J. Boult, J.K. Mrozek-Wilczkiewicz, A. Vinci, M. Bamber, J.C. Kaspera, W. Kramer-Marek, G. (2018). Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment. International journal of cancer, Vol.142 (11), pp. 2363-2374.

Khan, A.A. Paget, J.T. McLaughlin, M. Kyula, J.N. Wilkinson, M.J. Pencavel, T. Mansfield, D. Roulstone, V. Seth, R. Halle, M. Somaiah, N. Boult, J.K. Robinson, S.P. Pandha, H.S. Vile, R.G. Melcher, A.A. Harris, P.A. Harrington, K.J. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science translational medicine, Vol.10, pp. eaar2041-eaar2041.  show abstract

Heatley, N. Harrington, K.J. Thway, K. (2018). Warthin Tumor–Like Mucoepidermoid Carcinoma. International journal of surgical pathology, Vol.26 (1), pp. 31-33.

Gurney-Champion, O.J. McQuaid, D. Dunlop, A. Wong, K.H. Welsh, L.C. Riddell, A.M. Koh, D.-. Oelfke, U. Leach, M.O. Nutting, C.M. Bhide, S.A. Harrington, K.J. Panek, R. Newbold, K.L. (2018). MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy. International journal of radiation oncology*biology*physics, Vol.100 (2), pp. 306-316.

Smith, H.G. Wilkinson, M. Kyula-Currie, J. Roulstone, V. Mansfield, D. McLaughlin, M. Harrington, K. Hayes, A.J. (2018). Viral ILP combines with PD-1 Blockade to Improve Local and Distant Disease Control in Extremity Soft Tissue Sarcoma (ESTS). Annals of surgical oncology, Vol.25, pp. S46-S46.

Samson, A. Scott, K.J. Taggart, D. West, E.J. Wilson, E. Nuovo, G.J. Thomson, S. Corns, R. Mathew, R.K. Fuller, M.J. Kottke, T.J. Thompson, J.M. Ilett, E.J. Cockle, J.V. van Hille, P. Sivakumar, G. Polson, E.S. Turnbull, S.J. Appleton, E.S. Migneco, G. Rose, A.S. Coffey, M.C. Beirne, D.A. Collinson, F.J. Ralph, C. Alan Anthoney, D. Twelves, C.J. Furness, A.J. Quezada, S.A. Wurdak, H. Errington-Mais, F. Pandha, H. Harrington, K.J. Selby, P.J. Vile, R.G. Griffin, S.D. Stead, L.F. Short, S.C. Melcher, A.A. (2018). Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science translational medicine, Vol.10 (422), pp. eaam7577-eaam7577.  show abstract

Yip, K. Melcher, A. Harrington, K. Illidge, T. Nobes, J. Webster, A. Smith, D. Lorigan, P. Nathan, P. Larkin, J. (2018). Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma — Introducing the PERM Trial. Clinical oncology, Vol.30 (4), pp. 201-203.

Rooney, K.P. Miah, A.B. Bhide, S.A. Guerrero-Urbano, M.T. Sharabiani, M.T. Newbold, K.L. Grove, L. Harrington, K.J. Nutting, C.M. (2018). Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study. Radiotherapy and oncology, Vol.127 (1), pp. 43-48.

Wong, K.H. Panek, R. Dunlop, A. Mcquaid, D. Riddell, A. Welsh, L.C. Murray, I. Koh, D.-. Leach, M.O. Bhide, S.A. Nutting, C.M. Oyen, W.J. Harrington, K.J. Newbold, K.L. (2018). Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. European journal of nuclear medicine and molecular imaging, Vol.45 (5), pp. 759-767.

Comins, C. Simpson, G.R. Rogers, W. Relph, K. Harrington, K. Melcher, A. Roulstone, V. Kyula, J. Pandha, H. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer gene therapy, Vol.25 (5-6), pp. 148-160.

Grønhøj, C. Jensen, D.H. Dehlendorff, C. Marklund, L. Wagner, S. Mehanna, H. Munck-Wikland, E. Ramqvist, T. Näsman, A. Wittekindt, C. Würdemann, N. Sharma, S.J. Gattenlöhner, S. Kiss, K. Andersen, E. Spruce, R. Batis, N. Robinson, M. Harrington, K. Winter, S. Jones, T.M. Klussmann, J.P. Dalianis, T. Friborg, J. von Buchwald, C. (2018). Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams). British journal of cancer, Vol.118 (12), pp. 1672-1681.

Ferris, R.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K.J. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Lynch, M. Jayaprakash, V. Li, L. Gillison, M.L. (2018). Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral oncology, Vol.81, pp. 45-51.

Annels, N.E. Arif, M. Simpson, G.R. Denyer, M. Moller-Levet, C. Mansfield, D. Butler, R. Shafren, D. Au, G. Knowles, M. Harrington, K. Vile, R. Melcher, A. Pandha, H. (2018). Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. Molecular therapy - oncolytics, Vol.9, pp. 1-12.

Agaimy, A. Fonseca, I. Martins, C. Thway, K. Barrette, R. Harrington, K.J. Hartmann, A. French, C.A. Fisher, C. (2018). NUT Carcinoma of the Salivary Glands. The american journal of surgical pathology, Vol.42 (7), pp. 877-884.

Tree, A.C. Jones, K. Hafeez, S. Sharabiani, M.T. Harrington, K.J. Lalondrelle, S. Ahmed, M. Huddart, R.A. (2018). Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. International journal of radiation oncology*biology*physics, Vol.101 (5), pp. 1168-1171.

Dillon, M.T. Boylan, Z. Smith, D. Guevara, J. Mohammed, K. Peckitt, C. Saunders, M. Banerji, U. Clack, G. Smith, S.A. Spicer, J.F. Forster, M.D. Harrington, K.J. (2018). PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours. Clinical and translational radiation oncology, Vol.12, pp. 16-20.

Henderson, D.R. Murray, J.R. Gulliford, S.L. Tree, A.C. Harrington, K.J. Van As, N.J. (2018). An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clinical oncology, Vol.30 (9), pp. 539-547.

Gillison, M.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K.J. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Iglesias Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Monga, M. Lynch, M. Li, L. Ferris, R.L. (2018). CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. The oncologist, Vol.23 (9), pp. 1079-1082.

Tykodi, S.S. Schadendorf, D. Cella, D. Reck, M. Harrington, K. Wagner, S. Shaw, J.W. (2018). Patient-reported outcomes with nivolumab in advanced solid cancers. Cancer treatment reviews, Vol.70, pp. 75-87.

Allin, D.M. Shaikh, R. Carter, P. Thway, K. Sharabiani, M.T. Gonzales-de-Castro, D. O'Leary, B. Garcia-Murillas, I. Bhide, S. Hubank, M. Harrington, K. Kim, D. Newbold, K. (2018). Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. European journal of cancer, Vol.103, pp. 165-175.

Nutting, C.M. Morden, J.P. Beasley, M. Bhide, S. Cook, A. De Winton, E. Emson, M. Evans, M. Fresco, L. Gollins, S. Gujral, D. Harrington, K. Joseph, M. Lemon, C. Luxon, L. van den Blink, Q. Mendes, R. Miah, A. Newbold, K. Prestwich, R. Robinson, M. Sanghera, P. Simpson, J. Sivaramalingam, M. Srihari, N.N. Sydenham, M. Wells, E. Witts, S. Hall, E. (2018). Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). European journal of cancer, Vol.103, pp. 249-258.

Marabelle, A. Andtbacka, R. Harrington, K. Melero, I. Leidner, R. de Baere, T. Robert, C. Ascierto, P.A. Baurain, J.-. Imperiale, M. Rahimian, S. Tersago, D. Klumper, E. Hendriks, M. Kumar, R. Stern, M. Öhrling, K. Massacesi, C. Tchakov, I. Tse, A. Douillard, J.-. Tabernero, J. Haanen, J. Brody, J. (2018). Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). Annals of oncology, Vol.29 (11), pp. 2163-2174.

Bahig, H. Yuan, Y. Mohamed, A.S. Brock, K.K. Ng, S.P. Wang, J. Ding, Y. Hutcheson, K. McCulloch, M. Balter, P.A. Lai, S.Y. Al-Mamgani, A. Sonke, J.-. van der Heide, U.A. Nutting, C. Li, X.A. Robbins, J. Awan, M. Karam, I. Newbold, K. Harrington, K. Oelfke, U. Bhide, S. Philippens, M.E. Terhaard, C.H. McPartlin, A.J. Blanchard, P. Garden, A.S. Rosenthal, D.I. Gunn, G.B. Phan, J. Cazoulat, G. Aristophanous, M. McSpadden, K.K. Garcia, J.A. van den Berg, C.A. Raaijmakers, C.P. Kerkmeijer, L. Doornaert, P. Blinde, S. Frank, S.J. Fuller, C.D. (2018). Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clinical and translational radiation oncology, Vol.13, pp. 19-23.

Martins, C.D. Da Pieve, C. Burley, T.A. Smith, R. Ciobota, D.M. Allott, L. Harrington, K.J. Oyen, W.J. Smith, G. Kramer-Marek, G. (2018). HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. Clinical cancer research, Vol.24 (8), pp. 1853-1865.

Gujral, D.M. Long, M. Roe, J.W. Harrington, K.J. Nutting, C.M. (2017). Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer. Clinical oncology, Vol.29 (1), pp. 42-50.

Welsh, L. Panek, R. Riddell, A. Wong, K. Leach, M.O. Tavassoli, M. Rahman, D. Schmidt, M. Hurley, T. Grove, L. Richards, T. Koh, D.-. Nutting, C. Harrington, K. Newbold, K. Bhide, S. (2017). Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck. British journal of cancer, Vol.116 (1), pp. 28-35.

Dillon, M.T. Barker, H.E. Pedersen, M. Hafsi, H. Bhide, S.A. Newbold, K.L. Nutting, C.M. McLaughlin, M. Harrington, K.J. (2017). Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei. Molecular cancer therapeutics, Vol.16 (1), pp. 25-34.

McLaughlin, M. Barker, H.E. Khan, A.A. Pedersen, M. Dillon, M. Mansfield, D.C. Patel, R. Kyula, J.N. Bhide, S.A. Newbold, K.L. Nutting, C.M. Harrington, K.J. (2017). HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation. Bmc cancer, Vol.17, pp. 1-13.  show abstract

Panek, R. Welsh, L. Baker, L.C. Schmidt, M.A. Wong, K.H. Riddell, A.M. Koh, D.-. Dunlop, A. Mcquaid, D. d'Arcy, J.A. Bhide, S.A. Harrington, K.J. Nutting, C.M. Hopkinson, G. Richardson, C. Box, C. Eccles, S.A. Leach, M.O. Robinson, S.P. Newbold, K.L. (2017). Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. Clinical cancer research, Vol.23 (15), pp. 4233-4241.

Sundar, R. Valeri, N. Harrington, K.J. Yap, T.A. (2017). Combining Molecularly Targeted Agents: Is More Always Better?. Clinical cancer research, Vol.23 (5), pp. 1123-1125.

Ilett, E. Kottke, T. Thompson, J. Rajani, K. Zaidi, S. Evgin, L. Coffey, M. Ralph, C. Diaz, R. Pandha, H. Harrington, K. Selby, P. Bram, R. Melcher, A. Vile, R. (2017). Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. Gene therapy, Vol.24 (1), pp. 21-30.

Wong, K.H. Kuciejewska, A. Sharabiani, M.T. Ng-Cheng-Hin, B. Hoy, S. Hurley, T. Rydon, J. Grove, L. Santos, A. Ryugenji, M. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2017). A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. Radiotherapy and oncology, Vol.122 (2), pp. 207-211.

Guerreiro, F. Burgos, N. Dunlop, A. Wong, K. Petkar, I. Nutting, C. Harrington, K. Bhide, S. Newbold, K. Dearnaley, D. deSouza, N.M. Morgan, V.A. McClelland, J. Nill, S. Cardoso, M.J. Ourselin, S. Oelfke, U. Knopf, A.C. (2017). Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning. Phys med, Vol.35, pp. 7-17.  show abstract

Patel, R. Barker, H.E. Kyula, J. McLaughlin, M. Dillon, M.T. Schick, U. Hafsi, H. Thompson, A. Khoo, V. Harrington, K. Zaidi, S. (2017). An orally bioavailable Chkl inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and oncology, Vol.122 (3), pp. 470-475.

Wong, K.H. Panek, R. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2017). The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. The british journal of radiology, Vol.90 (1071), pp. 20160768-20160768.

Dean, J.A. Welsh, L.C. Wong, K.H. Aleksic, A. Dunne, E. Islam, M.R. Patel, A. Patel, P. Petkar, I. Phillips, I. Sham, J. Schick, U. Newbold, K.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Gulliford, S.L. (2017). Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical oncology, Vol.29 (4), pp. 263-273.

Petkar, I. Bhide, S. Newbold, K. Harrington, K. Nutting, C. (2017). Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?. Clinical oncology, Vol.29 (7), pp. e110-e118.

Harrington, K.J. Ferris, R.L. Blumenschein, G. Colevas, A.D. Fayette, J. Licitra, L. Kasper, S. Even, C. Vokes, E.E. Worden, F. Saba, N.F. Kiyota, N. Haddad, R. Tahara, M. Grünwald, V. Shaw, J.W. Monga, M. Lynch, M. Taylor, F. DeRosa, M. Morrissey, L. Cocks, K. Gillison, M.L. Guigay, J. (2017). Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. The lancet oncology, Vol.18 (8), pp. 1104-1115.

Lee, J.Y. Garcia-Murillas, I. Cutts, R.J. De Castro, D.G. Grove, L. Hurley, T. Wang, F. Nutting, C. Newbold, K. Harrington, K. Turner, N. Bhide, S. (2017). Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. British journal of cancer, Vol.117 (6), pp. 876-883.

Morgan, R. El-Tanani, M. Hunter, K.D. Harrington, K.J. Pandha, H.S. (2017). Targeting HOX/PBX dimers in cancer. Oncotarget, Vol.8 (19), pp. 32322-32331.

Richards, T.M. Hurley, T. Grove, L. Harrington, K.J. Carpenter, G.H. Proctor, G.B. Nutting, C.M. (2017). The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral diseases, Vol.23 (7), pp. 990-1000.

Harrington, K. Hall, E. Hawkins, M. Henry, A. MacKay, R. Maughan, T. McDonald, A. Nutting, C. Oelfke, U. Sebag-Montefiore, D. Sharma, R.A. van Herk, M. Faivre-Finn, C. (2017). Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). Clinical oncology, Vol.29 (11), pp. 707-710.

Kottke, T. Evgin, L. Shim, K.G. Rommelfanger, D. Boisgerault, N. Zaidi, S. Diaz, R.M. Thompson, J. Ilett, E. Coffey, M. Selby, P. Pandha, H. Harrington, K. Melcher, A. Vile, R. (2017). Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer immunology research, Vol.5 (11), pp. 1029-1045.

Alharbi, R.A. Pandha, H.S. Simpson, G.R. Pettengell, R. Poterlowicz, K. Thompson, A. Harrington, K. El-Tanani, M. Morgan, R. (2017). Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget, Vol.8 (52), pp. 89566-89579.

Wong, K.H. Panek, R. Welsh, L. Mcquaid, D. Dunlop, A. Riddell, A. Murray, I. Du, Y. Chua, S. Koh, D.-. Bhide, S. Nutting, C. Oyen, W.J. Harrington, K. Newbold, K.L. (2016). The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Journal of nuclear medicine, Vol.57 (12), pp. 1843-1850.

Barker, H.E. Patel, R. McLaughlin, M. Schick, U. Zaidi, S. Nutting, C.M. Newbold, K.L. Bhide, S. Harrington, K.J. (2016). CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy. Molecular cancer therapeutics, Vol.15 (9), pp. 2042-2054.

Rajani, K. Parrish, C. Kottke, T. Thompson, J. Zaidi, S. Ilett, L. Shim, K.G. Diaz, R.-. Pandha, H. Harrington, K. Coffey, M. Melcher, A. Vile, R. (2016). Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses. Molecular therapy, Vol.24 (1), pp. 166-174.

Gujral, D.M. Shah, B.N. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Contrast-enhanced ultrasound to assess plaque neovascularization in irradiated carotid arteries. International journal of cardiology, Vol.202, pp. 3-4.

Sacco, J.J. Evans, M. Harrington, K.J. Man, S. Powell, N. Shaw, R.J. Jones, T.M. (2016). Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001. Human vaccines & immunotherapeutics, Vol.12 (4), pp. 1085-1086.

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Hooper, J. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis. Radiotherapy and oncology, Vol.118 (2), pp. 323-329.

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Arterial Stiffness as a Biomarker of Radiation-Induced Carotid Atherosclerosis. Angiology, Vol.67 (3), pp. 266-271.

Roe, J.W. Carding, P.N. Drinnan, M.J. Harrington, K.J. Nutting, C.M. (2016). Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer. Head & neck, Vol.38 (S1), pp. E1436-E1444.

Dean, J.A. Welsh, L.C. McQuaid, D. Wong, K.H. Aleksic, A. Dunne, E. Islam, M.R. Patel, A. Patel, P. Petkar, I. Phillips, I. Sham, J. Newbold, K.L. Bhide, S.A. Harrington, K.J. Gulliford, S.L. Nutting, C.M. (2016). Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiotherapy and oncology, Vol.119 (1), pp. 166-171.

Mansfield, D.C. Kyula, J.N. Rosenfelder, N. Chao-Chu, J. Kramer-Marek, G. Khan, A.A. Roulstone, V. McLaughlin, M. Melcher, A.A. Vile, R.G. Pandha, H.S. Khoo, V. Harrington, K.J. (2016). Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Gene therapy, Vol.23 (4), pp. 357-368.

Mehanna, H. Franklin, N. Compton, N. Robinson, M. Powell, N. Biswas-Baldwin, N. Paleri, V. Hartley, A. Fresco, L. Al-Booz, H. Junor, E. El-Hariry, I. Roberts, S. Harrington, K. Ang, K.K. Dunn, J. Woodman, C. (2016). Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. Head & neck, Vol.38 (S1), pp. E1863-E1869.

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Clarke, P.M. Kerawala, C.J. Nutting, C.M. Rhys-Evans, P.H. Kazi, R. Harrington, K.J. (2016). Acoustic parameters of speech: Lack of correlation with perceptual and questionnaire-based speech evaluation in patients with oral and oropharyngeal cancer treated with primary surgery. Head neck, Vol.38 (5), pp. 670-676.  show abstract

Jones, T.M. De, M. Foran, B. Harrington, K. Mortimore, S. (2016). Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. The journal of laryngology & otology, Vol.130 (S2), pp. S75-S82.  show abstract

Shah, B.N. Gujral, D.M. Chahal, N.S. Harrington, K.J. Nutting, C.M. Senior, R. (2016). Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy A Contrast-Enhanced Ultrasound Study. Jacc-cardiovascular imaging, Vol.9 (6), pp. 668-675.

Wilkinson, M.J. Smith, H.G. McEntee, G. Kyula-Currie, J. Pencavel, T.D. Mansfield, D.C. Khan, A.A. Roulstone, V. Hayes, A.J. Harrington, K.J. (2016). Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis. Oncotarget, Vol.7 (49), pp. 81208-81222.

Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Senior, R. Harrington, K.J. Nutting, C.M. (2016). Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients?. Qjm, Vol.109 (6), pp. 383-389.

Panek, R. Welsh, L. Dunlop, A. Wong, K.H. Riddell, A.M. Koh, D.-. Schmidt, M.A. Doran, S. Mcquaid, D. Hopkinson, G. Richardson, C. Nutting, C.M. Bhide, S.A. Harrington, K.J. Robinson, S.P. Newbold, K.L. Leach, M.O. (2016). Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T. Journal of magnetic resonance imaging, Vol.44 (1), pp. 72-80.

Dean, J.A. Wong, K.H. Welsh, L.C. Jones, A.-. Schick, U. Newbold, K.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Gulliford, S.L. (2016). Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiotherapy and oncology, Vol.120 (1), pp. 21-27.

Gujral, D.M. Cheung, W.K. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Hooper, J. Senior, R. Tang, M.-. Harrington, K.J. Nutting, C.M. (2016). Contrast enhancement of carotid adventitial vasa vasorum as a biomarker of radiation-induced atherosclerosis. Radiotherapy and oncology, Vol.120 (1), pp. 63-68.

McQuaid, D. Dunlop, A. Nill, S. Franzese, C. Nutting, C.M. Harrington, K.J. Newbold, K.L. Bhide, S.A. (2016). Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers. Strahlentherapie und onkologie, Vol.192 (8), pp. 516-525.

Miah, A.B. Bhide, S.A. Del Rosario, L. Matthews, J. Nicol, R. Tanay, M.A. Gupta, S. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2016). Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. Clinical oncology, Vol.28 (8), pp. e61-e67.

Miah, A.B. Gulliford, S.L. Morden, J. Newbold, K.L. Bhide, S.A. Zaidi, S.H. Hall, E. Harrington, K.J. Nutting, C.M. (2016). Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy. Clinical oncology, Vol.28 (9), pp. e69-e76.

Bhide, S.A. Thway, K. Lee, J. Wong, K. Clarke, P. Newbold, K.L. Nutting, C.M. Harrington, K.J. (2016). Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. British journal of cancer, Vol.115 (7), pp. 825-830.

Richards, T.M. Bhide, S.A. Miah, A.B. Del Rosario, L. Bodla, S. Thway, K. Gujral, D.M. Rooney, K.P. Schick, U. McGovern, T. Grove, L. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2016). Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies. Clinical oncology, Vol.28 (9), pp. e77-e84.

Harrington, K.J. Bourhis, J. (2016). Reply to N F Saba and S J Wong. Journal of clinical oncology, Vol.34 (17), pp. 2073-2074.

Ferris, R.L. Blumenschein, G. Fayette, J. Guigay, J. Colevas, A.D. Licitra, L. Harrington, K. Kasper, S. Vokes, E.E. Even, C. Worden, F. Saba, N.F. Iglesias Docampo, L.C. Haddad, R. Rordorf, T. Kiyota, N. Tahara, M. Monga, M. Lynch, M. Geese, W.J. Kopit, J. Shaw, J.W. Gillison, M.L. (2016). Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. New england journal of medicine, Vol.375 (19), pp. 1856-1867.

Petkar, I. Rooney, K. Roe, J.W. Patterson, J.M. Bernstein, D. Tyler, J.M. Emson, M.A. Morden, J.P. Mertens, K. Miles, E. Beasley, M. Roques, T. Bhide, S.A. Newbold, K.L. Harrington, K.J. Hall, E. Nutting, C.M. (2016). DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. Bmc cancer, Vol.16 (1).

Morgan, R. Simpson, G. Gray, S. Gillett, C. Tabi, Z. Spicer, J. Harrington, K.J. Pandha, H.S. (2016). HOX transcription factors are potential targets and markers in malignant mesothelioma. Bmc cancer, Vol.16 (1).

Andtbacka, R.H. Agarwala, S.S. Ollila, D.W. Hallmeyer, S. Milhem, M. Amatruda, T. Nemunaitis, J.J. Harrington, K.J. Chen, L. Shilkrut, M. Ross, M. Kaufman, H.L. (2016). Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head & neck, Vol.38 (12), pp. 1752-1758.

Kaufman, H.L. Amatruda, T. Reid, T. Gonzalez, R. Glaspy, J. Whitman, E. Harrington, K. Nemunaitis, J. Zloza, A. Wolf, M. Senzer, N.N. (2016). Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study. Journal for immunotherapy of cancer, Vol.4 (1).

Wilkinson, M.J. Smith, H.G. Pencavel, T.D. Mansfield, D.C. Kyula-Currie, J. Khan, A.A. McEntee, G. Roulstone, V. Hayes, A.J. Harrington, K.J. (2016). Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma. International journal of cancer, Vol.139 (6), pp. 1414-1422.

Schache, A.G. Powell, N.G. Cuschieri, K.S. Robinson, M. Leary, S. Mehanna, H. Rapozo, D. Long, A. Cubie, H. Junor, E. Monaghan, H. Harrington, K.J. Nutting, C.M. Schick, U. Lau, A.S. Upile, N. Sheard, J. Brougham, K. West, C.M. Oguejiofor, K. Thomas, S. Ness, A.R. Pring, M. Thomas, G.J. King, E.V. McCance, D.J. James, J.A. Moran, M. Sloan, P. Shaw, R.J. Evans, M. Jones, T.M. (2016). HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. Cancer research, Vol.76 (22), pp. 6598-6606.

Panek, R. Schmidt, M.A. Borri, M. Koh, D.-. Riddell, A. Welsh, L. Dunlop, A. Powell, C. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. Leach, M.O. (2016). Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?. Medical physics, Vol.43 (11), pp. 6024-6032.

McEntee, G. Kyula, J.N. Mansfield, D. Smith, H. Wilkinson, M. Gregory, C. Roulstone, V. Coffey, M. Harrington, K.J. (2016). Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling. Oncotarget, Vol.7 (30), pp. 48517-48532.

Kottke, T. Shim, K.G. Alonso-Camino, V. Zaidi, S. Maria Diaz, R. Pulido, J. Thompson, J. Rajani, K.R. Evgin, L. Ilett, E. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2016). Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Molecular therapy - oncolytics, Vol.3.

Andtbacka, R.H. Kaufman, H.L. Collichio, F. Amatruda, T. Senzer, N. Chesney, J. Delman, K.A. Spitler, L.E. Puzanov, I. Agarwala, S.S. Milhem, M. Cranmer, L. Curti, B. Lewis, K. Ross, M. Guthrie, T. Linette, G.P. Daniels, G.A. Harrington, K. Middleton, M.R. Miller, W.H. Zager, J.S. Ye, Y. Yao, B. Li, A. Doleman, S. VanderWalde, A. Gansert, J. Coffin, R.S. (2015). Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. Journal of clinical oncology, Vol.33 (25), pp. 2780-2788.  show abstract

Bogaerts, J. Sydes, M.R. Keat, N. McConnell, A. Benson, A. Ho, A. Roth, A. Fortpied, C. Eng, C. Peckitt, C. Coens, C. Pettaway, C. Arnold, D. Hall, E. Marshall, E. Sclafani, F. Hatcher, H. Earl, H. Ray-Coquard, I. Paul, J. Blay, J.-. Whelan, J. Panageas, K. Wheatley, K. Harrington, K. Licitra, L. Billingham, L. Hensley, M. McCabe, M. Patel, P.M. Carvajal, R. Wilson, R. Glynne-Jones, R. McWilliams, R. Leyvraz, S. Rao, S. Nicholson, S. Filiaci, V. Negrouk, A. Lacombe, D. Dupont, E. Pauporté, I. Welch, J.J. Law, K. Trimble, T. Seymour, M. (2015). Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. Eur j cancer, Vol.51 (3), pp. 271-281.  show abstract

Seth, R. Khan, A.A. Pencavel, T.D. Wilkinson, M.J. Kyula, J.N. Simpson, G. Pandha, H. Melcher, A. Vile, R. Harris, P.A. Harrington, K.J. (2015). Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma. Plast reconstr surg, Vol.135 (2), pp. 475-487.  show abstract

Harrington, K.J. Puzanov, I. Hecht, J.R. Hodi, F.S. Szabo, Z. Murugappan, S. Kaufman, H.L. (2015). Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy. Expert review of anticancer therapy, Vol.15 (12), pp. 1389-1403.

Appleton, E.S. Turnbull, S. Ralph, C. West, E. Scott, K. Harrington, K. Pandha, H. Melcher, A. (2015). Talimogene laherparepvec in the treatment of melanoma. Expert opinion on biological therapy, Vol.15 (10), pp. 1517-1530.

Dean, J.A. Welsh, L.C. Gulliford, S.L. Harrington, K.J. Nutting, C.M. (2015). A novel method for delineation of oral mucosa for radiotherapy dose–response studies. Radiotherapy and oncology, Vol.115 (1), pp. 63-66.

Roulstone, V. Pedersen, M. Kyula, J. Mansfield, D. Khan, A.A. McEntee, G. Wilkinson, M. Karapanagiotou, E. Coffey, M. Marais, R. Jebar, A. Errington-Mais, F. Melcher, A. Vile, R. Pandha, H. McLaughlin, M. Harrington, K.J. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Mol ther, Vol.23 (5), pp. 931-942.  show abstract

Zaidi, S. Blanchard, M. Shim, K. Ilett, E. Rajani, K. Parrish, C. Boisgerault, N. Kottke, T. Thompson, J. Celis, E. Pulido, J. Selby, P. Pandha, H. Melcher, A. Harrington, K. Vile, R. (2015). Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents. Mol ther, Vol.23 (5), pp. 845-856.  show abstract

Miah, A.B. Schick, U. Bhide, S.A. Guerrero-Urbano, M.-. Clark, C.H. Bidmead, A.M. Bodla, S. Del Rosario, L. Thway, K. Wilson, P. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2015). A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes. Br j cancer, Vol.112 (1), pp. 32-38.  show abstract

Barker, H.E. Paget, J.T. Khan, A.A. Harrington, K.J. (2015). The tumour microenvironmentafter radiotherapy: mechanisms ofresistance and recurrence. Nature reviews cancer, Vol.15, pp. 409-425.  show abstract

Cheung, W.K. Gujral, D.M. Shah, B.N. Chahal, N.S. Bhattacharyya, S. Cosgrove, D.O. Eckersley, R.J. Harrington, K.J. Senior, R. Nutting, C.M. Tang, M.-. (2015). Attenuation Correction and Normalisation for Quantification of Contrast Enhancement in Ultrasound Images of Carotid Arteries. Ultrasound in medicine & biology, Vol.41 (7), pp. 1876-1883.

Dillon, M.T. Harrington, K.J. (2015). Human Papillomavirus–Negative Pharyngeal Cancer. Journal of clinical oncology, Vol.33 (29), pp. 3251-3261.  show abstract

Harrington, K. Temam, S. Mehanna, H. D'Cruz, A. Jain, M. D'Onofrio, I. Manikhas, G. Horvath, Z. Sun, Y. Dietzsch, S. Dubinsky, P. Holeckova, P. El-Hariry, I. Franklin, N. Biswas-Baldwin, N. Legenne, P. Wissel, P. Netherway, T. Farrell, J. Ellis, C. Wang-Silvanto, J. Amonkar, M. Ahmed, N. Santillana, S. Bourhis, J. (2015). Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. Journal of clinical oncology, Vol.33 (35), pp. 4202-4209.  show abstract

Otter, S. Schick, U. Gulliford, S. Lal, P. Franceschini, D. Newbold, K. Nutting, C. Harrington, K. Bhide, S. (2015). Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. International journal of radiation oncology*biology*physics, Vol.93 (3), pp. 507-515.

Wilkins, A. Furness, A. W Corbett, R. Bloomfield, A. Porta, N. Morris, S. Ali, Z. Larkin, J. Harrington, K. (2015). The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma. British journal of cancer, Vol.113 (9), pp. 1275-1281.

Schick, U. Kyula, J. Barker, H. Patel, R. Zaidi, S. Gregory, C. Hafsi, H. Roulstone, V. Deutsch, E. McLaughlin, M. Harrington, K. (2015). Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiotherapy and oncology, Vol.117 (2), pp. 364-375.

Blanchard, M. Shim, K.G. Grams, M.P. Rajani, K. Diaz, R.M. Furutani, K.M. Thompson, J. Olivier, K.R. Park, S.S. Markovic, S.N. Pandha, H. Melcher, A. Harrington, K. Zaidi, S. Vile, R. (2015). Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. International journal of radiation oncology*biology*physics, Vol.93 (3), pp. 577-587.

Welsh, L. Panek, R. McQuaid, D. Dunlop, A. Schmidt, M. Riddell, A. Koh, D.-. Doran, S. Murray, I. Du, Y. Chua, S. Hansen, V. Wong, K.H. Dean, J. Gulliford, S. Bhide, S. Leach, M.O. Nutting, C. Harrington, K. Newbold, K. (2015). Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. Radiation oncology, Vol.10 (1).

Dunlop, A. McQuaid, D. Nill, S. Murray, J. Poludniowski, G. Hansen, V.N. Bhide, S. Nutting, C. Harrington, K. Newbold, K. Oelfke, U. (2015). Comparison of CT number calibration techniques for CBCT-based dose calculation. Strahlentherapie und onkologie, Vol.191 (12), pp. 970-978.

Roulstone, V. Khan, K. Pandha, H.S. Rudman, S. Coffey, M. Gill, G.M. Melcher, A.A. Vile, R. Harrington, K.J. de Bono, J. Spicer, J. (2015). Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors. Clin cancer res, Vol.21 (6), pp. 1305-1312.  show abstract

Pencavel, T.D. Wilkinson, M.J. Mansfield, D.C. Khan, A.A. Seth, R. Karapanagiotou, E.M. Roulstone, V. Aguilar, R.J. Chen, N.G. Szalay, A.A. Hayes, A.J. Harrington, K.J. (2015). Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma. Int j cancer, Vol.136 (4), pp. 965-976.  show abstract

Jennings, V.A. Ilett, E.J. Scott, K.J. West, E.J. Vile, R. Pandha, H. Harrington, K. Young, A. Hall, G.D. Coffey, M. Selby, P. Errington-Mais, F. Melcher, A.A. (2014). Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International journal of cancer, Vol.134 (5), pp. 1091-1101.

Gujral, D.M. Chahal, N. Senior, R. Harrington, K.J. Nutting, C.M. (2014). Radiation-induced carotid artery atherosclerosis. Radiother oncol, Vol.110 (1), pp. 31-38.  show abstract

Taylor, G.S. Jia, H. Harrington, K. Lee, L.W. Turner, J. Ladell, K. Price, D.A. Tanday, M. Matthews, J. Roberts, C. Edwards, C. McGuigan, L. Hartley, A. Wilson, S. Hui, E.P. Chan, A.T. Rickinson, A.B. Steven, N.M. (2014). A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin cancer res, Vol.20 (19), pp. 5009-5022.  show abstract

Gujral, D.M. Piercy, D. Morden, J.P. Emson, M. Hall, E. Miah, A.B. Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2014). Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: a survey of centres participating in a national randomised controlled trial. Oral oncol, Vol.50 (2), pp. 141-146.  show abstract

Gujral, D.M. Shah, B.N. Chahal, N.S. Senior, R. Harrington, K.J. Nutting, C.M. (2014). Clinical features of radiation-induced carotid atherosclerosis. Clin oncol (r coll radiol), Vol.26 (2), pp. 94-102.  show abstract

Powell, C. Schick, U. Morden, J.P. Gulliford, S.L. Miah, A.B. Bhide, S. Newbold, K. Harrington, K.J. Nutting, C.M. (2014). Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother oncol, Vol.110 (3), pp. 416-421.  show abstract

Sarris, E.G. Harrington, K.J. Saif, M.W. Syrigos, K.N. (2014). Multimodal treatment strategies for elderly patients with head and neck cancer. Cancer treat rev, Vol.40 (3), pp. 465-475.  show abstract

Dillon, M.T. Good, J.S. Harrington, K.J. (2014). Selective targeting of the G2/M cell cycle checkpoint to improve the therapeutic index of radiotherapy. Clin oncol (r coll radiol), Vol.26 (5), pp. 257-265.  show abstract

Morgan, R. Boxall, A. Harrington, K.J. Simpson, G.R. Michael, A. Pandha, H.S. (2014). Targeting HOX transcription factors in prostate cancer. Bmc urology, Vol.14.

Dunlop, A. Welsh, L. Nutting, C. Harrington, K. Bhide, S. Newbold, K. (2014). SU-E-T-198: Hippocampal-Sparing Radiotherapy (HSRT) for Patients with Head and Neck Cancer (HNC) Using Intensity-Modulated Radiation Therapy (IMRT). Medical physics, Vol.41 (6Part14), pp. 268-268.

Dean, J. Welsh, L. Gulliford, S. Harrington, K. Nutting, C. (2014). SU-D-16A-02: A Novel Methodology for Accurate, Semi-Automated Delineation of Oral Mucosa for Radiation Therapy Dose-Response Studies. Medical physics, Vol.41 (6Part3), pp. 108-108.

Nemunaitis, J.J. Andtbacka, R.H. Ross, M. Amatruda, T. Chesney, J. Collichio, F.A. Harrington, K.J. Steven, N.M. Fourie, S. Dreosti, L. Li, A. Liu, K. Shilkrut, M. Coffin, R. Kaufman, H. (2014). Results of the Extension Trial of Optim, a Multicenter, Randomized Phase 3 Trial of Talimogene Laherparepvec (T-Vec) Vs Gm-Csf for Unresected Stage Iiib-Iv Melanoma. Annals of oncology, Vol.25, pp. iv382-iv382.

Lynch, J. Lal, P. Schick, U. Nutting, C.M. Newbold, K. Harrington, K. Bhide, S. (2014). Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral oncol, Vol.50 (9), pp. 901-906.  show abstract

Irune, E. Dwivedi, R.C. Nutting, C.M. Harrington, K.J. (2014). Treatment-related dysgeusia in head and neck cancer patients. Cancer treat rev, Vol.40 (9), pp. 1106-1117.  show abstract

Morgan, R. Gray, S. Gillett, C. Tabi, Z. Launchbury, F. Spicer, J. Harrington, K. Pandha, H.S. (2014). HOX TRANSCRIPTION FACTORS ARE POTENTIAL TARGETS AND MARKERS IN MALIGNANT MESOTHELIOMA. Anticancer research, Vol.34 (10), pp. 6069-6071.

Ilett, E. Kottke, T. Donnelly, O. Thompson, J. Willmon, C. Diaz, R. Zaidi, S. Coffey, M. Selby, P. Harrington, K. Pandha, H. Melcher, A. Vile, R. (2014). Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus. Mol ther, Vol.22 (10), pp. 1851-1863.  show abstract

Alonso-Camino, V. Rajani, K. Kottke, T. Rommelfanger-Konkol, D. Zaidi, S. Thompson, J. Pulido, J. Ilett, E. Donnelly, O. Selby, P. Pandha, H. Melcher, A. Harrington, K. Diaz, R.M. Vile, R. (2014). The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular therapy, Vol.22 (11), pp. 1936-1948.

Gujral, D.M. Miah, A.B. Bodla, S. Richards, T.M. Welsh, L. Schick, U. Powell, C.J. Clark, C.H. Bidmead, M.A. Grove, L. Guerrero-Urbano, T. Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2014). Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers. Oral oncol, Vol.50 (11), pp. 1089-1097.  show abstract

Alonso-Camino, V. Rajani, K. Kottke, T. Rommelfanger-Konkol, D. Zaidi, S. Thompson, J. Pulido, J. Ilett, E. Donnelly, O. Selby, P. Pandha, H. Melcher, A. Harrington, K. Diaz, R.M. Vile, R. (2014). The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site. Mol ther, Vol.22 (11), pp. 1936-1948.  show abstract

Roe, J.W. Drinnan, M.J. Carding, P.N. Harrington, K.J. Nutting, C.M. (2014). Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer How important is dysphagia?. Oral oncol, Vol.50 (12), pp. 1182-1187.  show abstract

Welsh, L.C. Dunlop, A.W. McGovern, T. McQuaid, D. Dean, J.A. Gulliford, S.L. Bhide, S.A. Harrington, K.J. Nutting, C.M. Newbold, K.L. (2014). Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin oncol (r coll radiol), Vol.26 (12), pp. 765-775.  show abstract

Kyula, J.N. Khan, A.A. Mansfield, D. Karapanagiotou, E.M. McLaughlin, M. Roulstone, V. Zaidi, S. Pencavel, T. Touchefeu, Y. Seth, R. Chen, N.G. Yu, Y.A. Zhang, Q. Melcher, A.A. Vile, R.G. Pandha, H.S. Ajaz, M. Szalay, A.A. Harrington, K.J. (2014). Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling. Oncogene, Vol.33 (13), pp. 1700-1712.  show abstract

Burtness, B. Bourhis, J.P. Vermorken, J.B. Harrington, K.J. Cohen, E.E. (2014). Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial. Trials, Vol.15.

Dean, J.A. Welsh, L.C. Harrington, K.J. Nutting, C.M. Gulliford, S. (2014). Predictive Modelling of Toxicity Resulting from Radiotherapy Treatments of Head and Neck Cancer. Corr, Vol.abs/1412.6399.

Donnelly, O.G. Errington-Mais, F. Steele, L. Hadac, E. Jennings, V. Scott, K. Peach, H. Phillips, R.M. Bond, J. Pandha, H. Harrington, K. Vile, R. Russell, S. Selby, P. Melcher, A.A. (2013). Measles virus causes immunogenic cell death in human melanoma. Gene therapy, Vol.20 (1), pp. 7-15.

Powell, C. Schmidt, M. Borri, M. Koh, D.-. Partridge, M. Riddell, A. Cook, G. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. (2013). Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother oncol, Vol.106 (1), pp. 112-117.  show abstract

Mansfield, D. Pencavel, T. Kyula, J.N. Zaidi, S. Roulstone, V. Thway, K. Karapanagiotou, L. Khan, A.A. McLaughlin, M. Touchefeu, Y. Seth, R. Melcher, A.A. Vile, R.G. Pandha, H.S. Harrington, K.J. (2013). Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral oncology, Vol.49 (2), pp. 108-118.

Miah, A.B. Gulliford, S.L. Bhide, S.A. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2013). The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT. Radiother oncol, Vol.106 (3), pp. 346-351.  show abstract

Miah, A.B. Gulliford, S.L. Clark, C.H. Bhide, S.A. Zaidi, S.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2013). Dose-response analysis of parotid gland function: what is the best measure of xerostomia?. Radiother oncol, Vol.106 (3), pp. 341-345.  show abstract

Roulstone, V. Twigger, K. Zaidi, S. Pencavel, T. Kyula, J.N. White, C. McLaughlin, M. Seth, R. Karapanagiotou, E.M. Mansfield, D. Coffey, M. Nuovo, G. Vile, R.G. Pandha, H.S. Melcher, A.A. Harrington, K.J. (2013). Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene therapy, Vol.20 (5), pp. 521-528.

Franzese, C. Gujral, D.M. Good, J. Thway, K. Harrington, K.J. (2013). Radical radiotherapy for radiation-induced malignancy in the context of Hereditary retinoblastoma. Clin oncol (r coll radiol), Vol.25 (5), pp. 330-331.

Welsh, L. Powell, C. Pratt, B. Harrington, K. Nutting, C. Harmer, C. Newbold, K. (2013). Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer. J clin endocrinol metab, Vol.98 (5), pp. 1819-1825.  show abstract

Harrington, K. Berrier, A. Robinson, M. Remenar, E. Housset, M. de Mendoza, F.H. Fayette, J. Mehanna, H. El-Hariry, I. Compton, N. Franklin, N. Biswas-Baldwin, N. Lau, M. Legenne, P. Kumar, R. (2013). Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. Eur j cancer, Vol.49 (7), pp. 1609-1618.  show abstract

Wilkins, A.C. Rosenfelder, N. Schick, U. Gupta, S. Thway, K. Nutting, C.M. Harrington, K.J. Newbold, K. Bhide, S.A. (2013). Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis. Oral oncol, Vol.49 (6), pp. 615-619.  show abstract

Giannopoulou, A. Gkiozos, I. Harrington, K.J. Syrigos, K.N. (2013). Thymoma and radiation therapy: a systematic review of medical treatment. Expert review of anticancer therapy, Vol.13 (6), pp. 759-766.

Calvo, F. Ege, N. Grande-Garcia, A. Hooper, S. Jenkins, R.P. Chaudhry, S.I. Harrington, K. Williamson, P. Moeendarbary, E. Charras, G. Sahai, E. (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nature cell biology, Vol.15 (6), pp. 637-+.

Box, C. Mendiola, M. Gowan, S. Box, G.M. Valenti, M. Brandon, A.D. Al-Lazikani, B. Rogers, S.J. Wilkins, A. Harrington, K.J. Eccles, S.A. (2013). A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. Eur j cancer, Vol.49 (11), pp. 2512-2521.  show abstract

Touchefeu, Y. Khan, A.A. Borst, G. Zaidi, S.H. McLaughlin, M. Roulstone, V. Mansfield, D. Kyula, J. Pencavel, T. Karapanagiotou, E.M. Clayton, J. Federspiel, M.J. Russell, S.J. Garrett, M. Collins, I. Harrington, K.J. (2013). Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Radiotherapy and oncology, Vol.108 (1), pp. 24-31.

Perlikos, F. Harrington, K.J. Syrigos, K.N. (2013). Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Critical reviews in oncology hematology, Vol.87 (1), pp. 1-11.

Chaudhry, S.I. Hooper, S. Nye, E. Williamson, P. Harrington, K. Sahai, E. (2013). Autocrine IL-1 beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine INF alpha, signalling to carcinoma-associated fibroblasts. Oncogene, Vol.32 (6), pp. 747-758.

Boisgerault, N. Kottke, T. Pulido, J. Thompson, J. Diaz, R.M. Rommelfanger-Konkol, D. Embry, A. Saenz, D. Poeschla, E. Pandha, H. Harrington, K. Melcher, A. Selby, P. Vile, R. (2013). Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular therapy, Vol.21 (8), pp. 1507-1516.

Donnelly, O. Harrington, K. Melcher, A. Pandha, H. (2013). Live viruses to treat cancer. Journal of the royal society of medicine, Vol.106 (8), pp. 310-314.

Kyula, J.N. Khan, A.A. Wilkinson, M.J. Mansfield, D. Harrington, K.J. (2013). Radiation lays down covering fire for viral shock troops. Oncotarget, Vol.4, pp. 1329-1330.

Pencavel, T. Seth, R. Khan, A. Wilkinson, M. Hayes, A. Harrington, K. (2013). Isolated limb perfusion with melphalan, tnfa and oncolytic vaccinia virus delays tumour growth and prolongs survival in a rat model of locally-advanced extremity sarcoma. Int j surg, Vol.11 (8), p. 590.

Good, J.S. Harrington, K.J. (2013). The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. Clin oncol (r coll radiol), Vol.25 (10), pp. 569-577.  show abstract

Kottke, T. Boisgerault, N. Diaz, R.M. Donnelly, O. Rommelfanger-Konkol, D. Pulido, J. Thompson, J. Mukhopadhyay, D. Kaspar, R. Coffey, M. Pandha, H. Melcher, A. Harrington, K. Selby, P. Vile, R. (2013). Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature medicine, Vol.19 (12), pp. 1625-1631.

Borst, G.R. McLaughlin, M. Kyula, J.N. Neijenhuis, S. Khan, A. Good, J. Zaidi, S. Powell, N.G. Meier, P. Collins, I. Garrett, M.D. Verheij, M. Harrington, K.J. (2013). Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106. International journal of radiation oncology biology physics, Vol.85 (4), pp. 1110-1118.

Harrington, K.J. (2013). Oncolytic Virotherapy Needs Trials, Not Access Programs. Clinical cancer research, Vol.19 (10), pp. 2595-2597.

Adair, R.A. Scott, K.J. Fraser, S. Errington-Mais, F. Pandha, H. Coffey, M. Selby, P. Cook, G.P. Vile, R. Harrington, K.J. Toogood, G. Melcher, A.A. (2013). Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells. International journal of cancer, Vol.132 (10), pp. 2327-2338.

Harrington, K.J. (2013). Oncolytic viruses: methods and protocols. Br j cancer, Vol.108 (3), p. 735.

Bhide, S.A. Ahmed, M. Newbold, K. Harrington, K.J. Nutting, C.M. (2012). The role of intensity modulated radiotherapy in advanced oral cavity carcinoma. J cancer res ther, Vol.8 Suppl 1, pp. S67-S71.  show abstract

Karapanagiotou, E.M. Roulstone, V. Twigger, K. Ball, M. Tanay, M. Nutting, C. Newbold, K. Gore, M.E. Larkin, J. Syrigos, K.N. Coffey, M. Thompson, B. Mettinger, K. Vile, R.G. Pandha, H.S. Hall, G.D. Melcher, A.A. Chester, J. Harrington, K.J. (2012). Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin cancer res, Vol.18 (7), pp. 2080-2089.  show abstract

Dwivedi, R.C. Rose, S.S. Chisholm, E.J. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Development and validation of first-ever speech-specific perceptual speech evaluation tool for patients with head and neck cancer: the London speech evaluation (LSE) scale. Head neck, Vol.34 (1), pp. 94-103.  show abstract

Schick, U. Gujral, D.M. Richards, T.M. Harrington, K.J. Nutting, C.M. (2012). Zalutumumab in head and neck cancer. Expert opin biol ther, Vol.12 (1), pp. 119-125.  show abstract

Miah, A.B. Bhide, S.A. Guerrero-Urbano, M.T. Clark, C. Bidmead, A.M. St Rose, S. Barbachano, Y. A'hern, R. Tanay, M. Hickey, J. Nicol, R. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int j radiat oncol biol phys, Vol.82 (2), pp. 539-547.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Youssefi, P. Hassan, M.S. Khan, A.S. Elmiyeh, B. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur arch otorhinolaryngol, Vol.269 (2), pp. 591-599.  show abstract

Roe, J.W. Carding, P.N. Rhys-Evans, P.H. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - a web-based survey. Oral oncol, Vol.48 (4), pp. 343-348.  show abstract

Buettner, F. Miah, A.B. Gulliford, S.L. Hall, E. Harrington, K.J. Webb, S. Partridge, M. Nutting, C.M. (2012). Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother oncol, Vol.103 (1), pp. 82-87.  show abstract

Bhide, S.A. Gulliford, S. Schick, U. Miah, A. Zaidi, S. Newbold, K. Nutting, C.M. Harrington, K.J. (2012). Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiother oncol, Vol.103 (1), pp. 88-91.  show abstract

Dwivedi, R.C. Chisholm, E.J. Khan, A.S. Harris, N.J. Bhide, S.A. St Rose, S. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery. Eur arch otorhinolaryngol, Vol.269 (4), pp. 1233-1239.  show abstract

Touchefeu, Y. Schick, U. Harrington, K.J. (2012). [Measles virus: a future therapeutic agent in oncology?]. Med sci (paris), Vol.28 (4), pp. 388-394.  show abstract

Pulido, J. Kottke, T. Thompson, J. Galivo, F. Wongthida, P. Diaz, R.M. Rommelfanger, D. Ilett, E. Pease, L. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2012). Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nature biotechnology, Vol.30 (4), pp. 336-343.

Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2012). Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br j radiol, Vol.85 (1013), pp. 487-494.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Bisase, B. Amen, F. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. Oral oncol, Vol.48 (6), pp. 547-553.  show abstract

Murray, J.R. Williams, G.R. Harrington, K.J. Newbold, K. Nutting, C.M. (2012). Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?. Clin endocrinol (oxf), Vol.77 (1), pp. 155-157.

Donnelly, O.G. Errington-Mais, F. Prestwich, R. Harrington, K. Pandha, H. Vile, R. Melcher, A.A. (2012). Recent Clinical Experience with Oncolytic Viruses. Current pharmaceutical biotechnology, Vol.13 (9), pp. 1834-1841.

Gulliford, S.L. Miah, A.B. Brennan, S. McQuaid, D. Clark, C.H. Partridge, M. Harrington, K.J. Morden, J.P. Hall, E. Nutting, C.M. (2012). Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother oncol, Vol.104, pp. 205-212.  show abstract

Khattak, M. Gore, M. Larkin, J. Strauss, D. Thomas, M. Hayes, A. Harrington, K. (2012). Adjuvant nodal irradiation in melanoma. Lancet oncol, Vol.13 (8), pp. e326-e327.

Donnelly, O. Vile, R. Pandha, H. Harrington, K. Melcher, A. (2012). The Hitchhiker's Guide to Virotherapy. Oncotarget, Vol.3 (8), pp. 735-736.

Seth, R. Khan, A.A. Pencavel, T. Harrington, K.J. Harris, P.A. (2012). Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction. Lancet oncol, Vol.13 (9), pp. e392-e402.  show abstract

Nuovo, G.J. Garofalo, M. Valeri, N. Roulstone, V. Volinia, S. Cohn, D.E. Phelps, M. Harrington, K.J. Vile, R. Melcher, A. Galanis, E. Sehl, S. Adair, R. Scott, K. Rose, A. Toogood, G. Coffey, M.C. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Modern pathology, Vol.25 (10), pp. 1333-1344.

Galanis, E. Markovic, S.N. Suman, V.J. Nuovo, G.J. Vile, R.G. Kottke, T.J. Nevala, W.K. Thompson, M.A. Lewis, J.E. Rumilla, K.M. Roulstone, V. Harrington, K. Linette, G.P. Maples, W.J. Coffey, M. Zwiebel, J. Kendra, K. (2012). Phase II Trial of Intravenous Administration of Reolysin (R) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. Molecular therapy, Vol.20 (10), pp. 1998-2003.

Morgan, R. Boxall, A. Harrington, K.J. Simpson, G.R. Gillett, C. Michael, A. Pandha, H.S. (2012). Targeting the HOX/PBX dimer in breast cancer. Breast cancer research and treatment, Vol.136 (2), pp. 389-398.

Harrington, K. (2012). Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer. Expert opinion on biological therapy, Vol.12 (12), pp. 1669-1678.  show abstract

Dwivedi, R.C. St Rose, S. Chisholm, E.J. Georgalas, C. Bisase, B. Amen, F. Kerawala, C.J. Clarke, P.M. Nutting, C.M. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2012). Evaluation of swallowing by Sydney Swallow Questionnaire (SSQ) in oral and oropharyngeal cancer patients treated with primary surgery. Dysphagia, Vol.27 (4), pp. 491-497.  show abstract

Adair, R.A. Roulstone, V. Scott, K.J. Morgan, R. Nuovo, G.J. Fuller, M. Beirne, D. West, E.J. Jennings, V.A. Rose, A. Kyula, J. Fraser, S. Dave, R. Anthoney, D.A. Merrick, A. Prestwich, R. Aldouri, A. Donnelly, O. Pandha, H. Coffey, M. Selby, P. Vile, R. Toogood, G. Harrington, K. Melcher, A.A. (2012). Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients. Science translational medicine, Vol.4 (138).

Twigger, K. Roulstone, V. Kyula, J. Karapanagiotou, E.M. Syrigos, K.N. Morgan, R. White, C. Bhide, S. Nuovo, G. Coffey, M. Thompson, B. Jebar, A. Errington, F. Melcher, A.A. Vile, R.G. Pandha, H.S. Harrington, K.J. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. Bmc cancer, Vol.12, p. 368.  show abstract

Simpson, G.R. Horvath, A. Annels, N.E. Pencavel, T. Metcalf, S. Seth, R. Peschard, P. Price, T. Coffin, R.S. Mostafid, H. Melcher, A.A. Harrington, K.J. Pandha, H.S. (2012). Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British journal of cancer, Vol.106 (3), pp. 496-507.

Zaidi, S. McLaughlin, M. Bhide, S.A. Eccles, S.A. Workman, P. Nutting, C.M. Huddart, R.A. Harrington, K.J. (2012). The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage. Plos one, Vol.7 (4), p. e35436.  show abstract

Newbold, K.L. Bhide, S. Convery, H. Harrington, K.J. Nutting, C.M. (2012). Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer. Med dosim, Vol.37 (3), pp. 293-295.  show abstract

Touchefeu, Y. Franken, P. Harrington, K.J. (2012). Radiovirotherapy: principles and prospects in oncology. Curr pharm des, Vol.18 (22), pp. 3313-3320.  show abstract

Lolkema, M.P. Arkenau, H.-. Harrington, K. Roxburgh, P. Morrison, R. Roulstone, V. Twigger, K. Coffey, M. Mettinger, K. Gill, G. Evans, T.R. de Bono, J.S. (2011). A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin cancer res, Vol.17 (3), pp. 581-588.  show abstract

Hidalgo-Carcedo, C. Hooper, S. Chaudhry, S.I. Williamson, P. Harrington, K. Leitinger, B. Sahai, E. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nature cell biology, Vol.13 (1), pp. 49-22.

Willmon, C. Diaz, R.M. Wongthida, P. Galivo, F. Kottke, T. Thompson, J. Albelda, S. Harrington, K. Melcher, A. Vile, R. (2011). Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. Molecular therapy, Vol.19 (1), pp. 140-10.

Whitcher, B. Schmid, V.J. Collins, D.J. Orton, M.R. Koh, D.-. Diaz de Corcuera, I. Parera, M. del Campo, J.M. deSouza, N.M. Leach, M.O. Harrington, K. El-Hariry, I.A. (2011). A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. Magnetic resonance materials in physics biology and medicine, Vol.24 (2), pp. 85-12.

Ilett, E.J. Barcena, M. Errington-Mais, F. Griffin, S. Harrington, K.J. Pandha, H.S. Coffey, M. Selby, P.J. Limpens, R.W. Mommaas, M. Hoeben, R.C. Vile, R.G. Melcher, A.A. (2011). Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization. Clinical cancer research, Vol.17 (9), pp. 2767-10.

Kottke, T. Errington, F. Pulido, J. Galivo, F. Thompson, J. Wongthida, P. Diaz, R.M. Chong, H. Ilett, E. Chester, J. Pandha, H. Harrington, K. Selby, P. Melcher, A. Vile, R. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature medicine, Vol.17 (7), pp. 854-7.

Syrigos, K.N. Karapanagiotou, E. Boura, P. Manegold, C. Harrington, K. (2011). Bevacizumab-Induced Hypertension Pathogenesis and Management. Biodrugs, Vol.25 (3), pp. 159-11.

Sayed, S.I. Dwivedi, R.C. Katna, R. Garg, A. Pathak, K.A. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2011). Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral oncology, Vol.47 (4), pp. 237-7.

Touchefeu, Y. Vassaux, G. Harrington, K.J. (2011). Oncolytic viruses in radiation oncology. Radiotherapy and oncology, Vol.99 (3), pp. 262-9.

Richard-Fiardo, P. Franken, P.R. Harrington, K.J. Vassaux, G. Cambien, B. (2011). The use of molecular imaging of gene expression by radiotracers in gene therapy. Expert opinion on biological therapy, Vol.11 (10), pp. 1273-13.

Dwivedi, R.C. Dwivedi, R.C. Kazi, R. Kanwar, N. Nutting, C.M. Harrington, K.J. Rhys-Evans, P.H. (2011). Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?. Anz journal of surgery, Vol.81 (9), pp. 581-4.

Kottke, T. Chester, J. Ilett, E. Thompson, J. Diaz, R. Coffey, M. Selby, P. Nuovo, G. Pulido, J. Mukhopadhyay, D. Pandha, H. Harrington, K. Melcher, A. Vile, R. (2011). Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy. Molecular therapy, Vol.19 (10), pp. 1802-11.

Harrington, K. (2011). Virotherapy in the UK. Human gene therapy, Vol.22 (10), pp. A12-1.

Nutting, C.M. Morden, J.P. Harrington, K.J. Urbano, T.G. Bhide, S.A. Clark, C. Miles, E.A. Miah, A.B. Newbold, K. Tanay, M. Adab, F. Jefferies, S.J. Scrase, C. Yap, B.K. A'Hern, R.P. Sydenham, M.A. Emson, M. Hall, E. PARSPORT trial management group, (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet oncol, Vol.12 (2), pp. 127-136.  show abstract

Luangdilok, S. Box, C. Harrington, K. Rhŷs-Evans, P. Eccles, S. (2011). MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur j cancer, Vol.47 (4), pp. 520-529.  show abstract

Dwivedi, R.C. St Rose, S. Roe, J.W. Chisholm, E. Elmiyeh, B. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2011). First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer. Head neck, Vol.33 (3), pp. 341-348.  show abstract

Heinemann, L. Simpson, G.R. Boxall, A. Kottke, T. Relph, K.L. Vile, R. Melcher, A. Prestwich, R. Harrington, K.J. Morgan, R. Pandha, H.S. (2011). Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. Bmc cancer, Vol.11, p. 9.

Ahmed, M. Barbachano, Y. Riddell, A. Hickey, J. Newbold, K.L. Viros, A. Harrington, K.J. Marais, R. Nutting, C.M. (2011). Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population. Eur j endocrinol, Vol.165 (2), pp. 315-322.  show abstract

Bourke, M.G. Salwa, S. Harrington, K.J. Kucharczyk, M.J. Forde, P.F. de Kruijf, M. Soden, D. Tangney, M. Collins, J.K. O'Sullivan, G.C. (2011). The emerging role of viruses in the treatment of solid tumours. Cancer treatment reviews, Vol.37 (8), pp. 618-632.

Morgan, R. Michael, A. Bhatt, A. Harrington, K. Boxall, A. Annels, N. Pandha, H. (2011). Abstract 3100: HOX transcription factors promote cell survival in breast cancer. Cellular and molecular biology, .

Sourisseau, T. Harrington, K.J. Muller, W.J. Marshall, C.J. White, D.E. (2011). Changes in tumor tissue organization in collagen-I sensitize cells to ionizing radiation in an ex vivo model of solid mammary tumor growth and local invasion. Cell cycle, Vol.10 (22), pp. 3979-3981.

Pedersen, J.V. Karapanagiotou, E.M. Biondo, A. Tunariu, N. Puglisi, M. Denholm, K.A. Sassi, S. Mansfield, D. Yap, T.A. De Bono, J.S. Harrington, K.J. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. Journal of clinical oncology, Vol.29 (15).

Pedersen, J.V. Karapanagiotou, E.M. Biondo, A. Tunariu, N. Puglisi, M. Denholm, K.A. Sassi, S. Mansfield, D. Yap, T.A. De Bono, J.S. Harrington, K.J. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. J clin oncol, Vol.29 (15_suppl), p. 2577.  show abstract

Steven, N.M. Harrington, K.J. Lee, L. Jia, H. Tanday, M.K. Roberts, C. Edwards, C. McGuigan, L. Hartley, A.G. Viskaduraki, M. Hui, E.P. Chan, A.T. Rickinson, A.B. Taylor, G.S. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. J clin oncol, Vol.29 (15_suppl), p. e13028.  show abstract

Steven, N.M. Harrington, K.J. Lee, L. Jia, H. Tanday, M.K. Roberts, C. Edwards, C. McGuigan, L. Hartley, A.G. Viskaduraki, M. Hui, E.P. Chan, A.T. Rickinson, A.B. Taylor, G.S. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. Journal of clinical oncology, Vol.29 (15).

Steele, L. Errington, F. Prestwich, R. Ilett, E. Harrington, K. Pandha, H. Coffey, M. Selby, P. Vile, R. Melcher, A. (2011). Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming. Molecular cancer, Vol.10, p. 13.

Harrington, K.J. Billingham, L.J. Brunner, T.B. Burnet, N.G. Chan, C.S. Hoskin, P. Mackay, R.I. Maughan, T.S. Macdougall, J. McKenna, W.G. Nutting, C.M. Oliver, A. Plummer, R. Stratford, I.J. Illidge, T. (2011). Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br j cancer, Vol.105 (5), pp. 628-639.

del Campo, J.M. Hitt, R. Sebastian, P. Carracedo, C. Lokanatha, D. Bourhis, J. Temam, S. Cupissol, D. De Raucourt, D. Maroudias, N. Nutting, C.M. Compton, N. Midwinter, D. Downie, L. Biswas-Baldwin, N. El-Hariry, I. Harrington, K.J. (2011). Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. British journal of cancer, Vol.105 (5), pp. 618-10.

Charpidou, A. Gkiozos, I. Konstantinou, M. Eleftheraki, A. Demertzis, P. Harrington, K. Polyzos, A. Syrigos, K.N. (2011). Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. Cancer letters, Vol.304 (2), pp. 144-10.

Kottke, T. Hall, G. Pulido, J. Diaz, R.M. Thompson, J. Chong, H. Selby, P. Coffey, M. Pandha, H. Chester, J. Melcher, A. Harrington, K. Vile, R. (2010). Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. Journal of clinical investigation, Vol.120 (5), pp. 1551-10.

Hingorani, M. Spitzweg, C. Vassaux, G. Newbold, K. Melcher, A. Pandha, H. Vile, R. Harrington, K. (2010). The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery. Current cancer drug targets, Vol.10 (2), pp. 242-26.

Dandekar, P. Partridge, M. Kazi, R. Nutting, C. Harrington, K. Newbold, K. (2010). Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. Indian journal of cancer, Vol.47 (3), pp. 260-7.

Khan, A. Smellie, J. Nutting, C. Harrington, K. Newbold, K. (2010). Familial Nonmedullary Thyroid Cancer: A Review of the Genetics. Thyroid, Vol.20 (7), pp. 795-7.

Harrington, K.J. Karapanagiotou, E.M. Roulstone, V. Twigger, K.R. White, C.L. Vidal, L. Beirne, D. Prestwich, R. Newbold, K. Ahmed, M. Thway, K. Nutting, C.M. Coffey, M. Harris, D. Vile, R.G. Pandha, H.S. Debono, J.S. Melcher, A.A. (2010). Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin cancer res, Vol.16 (11), pp. 3067-3077.  show abstract

Powell, C. Mikropoulos, C. Kaye, S.B. Nutting, C.M. Bhide, S.A. Newbold, K. Harrington, K.J. (2010). Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. Cancer treatment reviews, Vol.36 (7), pp. 566-10.

Harrington, K.J. (2010). Topical treatment for oral cancers Winners and losers and oncolytic adenoviruses: who should be down in the mouth?. Gene therapy, Vol.17 (12), pp. 1421-2.

Heinemann, L. Simpson, G.R. Annels, N.E. Vile, R. Melcher, A. Prestwich, R. Harrington, K.J. Pandha, H.S. (2010). The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis. Molecular therapy, Vol.18 (12), pp. 2085-9.

Bhide, S.A. Gulliford, S. Fowler, J. Rosenfelder, N. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. Radiotherapy and oncology, Vol.97 (1), pp. 86-6.

Hingorani, M. White, C.L. Zaidi, S. Pandha, H.S. Melcher, A.A. Bhide, S.A. Nutting, C.M. Syrigos, K.N. Vile, R.G. Vassaux, G. Harrington, K.J. (2010). Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair. Molecular therapy, Vol.18 (9), pp. 1599-7.

Harrington, K.J. Hingorani, M. Tanay, M.A. Hickey, J. Bhide, S.A. Clarke, P.M. Renouf, L.C. Thway, K. Sibtain, A. McNeish, I.A. Newbold, K.L. Goldsweig, H. Coffin, R. Nutting, C.M. (2010). Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck. Clinical cancer research, Vol.16 (15), pp. 4005-11.

Merron, A. Baril, P. Martin-Duque, P. de la Vieja, A. Tran, L. Briat, A. Harrington, K.J. McNeish, I.A. Vassaux, G. (2010). Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. European journal of nuclear medicine and molecular imaging, Vol.37 (7), pp. 1377-9.

Harrington, K.J. Nutting, C.M. (2010). Bravo for PRAVO. Lancet oncology, Vol.11 (5), pp. 407-2.

Bhide, S.A. Davies, M. Burke, K. McNair, H.A. Hansen, V. Barbachano, Y. El-Hariry, I.A. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY. International journal of radiation oncology biology physics, Vol.76 (5), pp. 1360-9.

Ahmed, M. Schmidt, M. Sohaib, A. Kong, C. Burke, K. Richardson, C. Usher, M. Brennan, S. Riddell, A. Davies, M. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - A study using flexible surface coils. Radiotherapy and oncology, Vol.94 (2), pp. 161-7.

Harrington, K.J. (2010). Rash conclusions from a phase 3 study of cetuximab?. Lancet oncology, Vol.11 (1), pp. 2-2.

Ismail, M. Morgan, R. Harrington, K. Davies, J. Pandha, H. (2010). Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model. Cryobiology, Vol.61 (3), pp. 268-7.

Scott-Brown, M. Miah, A. Harrington, K. Nutting, C. (2010). Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy. Radiotherapy and oncology, Vol.97 (2), pp. 249-9.

Maughan, T.S. Illidge, T.M. Hoskin, P. McKenna, W.G. Brunner, T.B. Stratford, I.J. Harrington, K.J. Plummer, R. Billingham, L.J. Nutting, C. Burnet, N.G. Mackay, R.I. Oliver, A. Young, C. Chan, C.S. (2010). Radiotherapy Research Priorities for the UK. Clinical oncology, Vol.22 (8), pp. 707-3.

Bhide, S.A. Newbold, K.L. Harrington, K.J. Nutting, C.M. (2010). Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers. Expert review of anticancer therapy, Vol.10 (3), pp. 297-4.

Sayed, S.I. Manikantan, K. Khode, S. Jagade, M. Kasbekar, V.G. Shah, R. Palav, R.S. Nutting, C.M. Harrington, K.J. Rhys-Evans, P. Kazi, R. (2010). Tracheo-oesophageal Party Wall Thickness in Laryngectomised Patients in India: Implications for Surgical Voice Restoration. Journal of surgical oncology, Vol.101 (1), pp. 78-6.

Harrington, K.J. Vile, R.G. Melcher, A. Chester, J. Pandha, H.S. (2010). Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine growth factor rev, Vol.21 (2-3), pp. 91-98.  show abstract

Dwivedi, R.C. St Rose, S. Roe, J.W. Khan, A.S. Pepper, C. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2010). Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral oncol, Vol.46 (4), pp. e10-e14.  show abstract

Dwivedi, R.C. Kazi, R. Agrawal, N. Chisholm, E. St Rose, S. Elmiyeh, B. Rennie, C. Pepper, C. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. (2010). Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma. Oral oncol, Vol.46 (5), pp. 330-335.  show abstract

Harrington, K.J. Kazi, R. Bhide, S.A. Newbold, K. Nutting, C.M. (2010). Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. Indian j cancer, Vol.47 (3), pp. 248-259.  show abstract

Bhide, S.A. Kazi, R. Newbold, K. Harrington, K.J. Nutting, C.M. (2010). The role of intensity-modulated radiotherapy in head and neck cancer. Indian j cancer, Vol.47 (3), pp. 267-273.  show abstract

Powell, C. Newbold, K. Harrington, K.J. Bhide, S.A. Nutting, C.M. (2010). External beam radiotherapy for differentiated thyroid cancer. Clin oncol (r coll radiol), Vol.22 (6), pp. 456-463.  show abstract

Pencavel, T. Seth, R. Hayes, A. Melcher, A. Pandha, H. Vile, R. Harrington, K.J. (2010). Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?. Gene ther, Vol.17 (8), pp. 949-960.  show abstract

Roe, J.W. Carding, P.N. Dwivedi, R.C. Kazi, R.A. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. (2010). Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - a systematic review. Oral oncol, Vol.46 (10), pp. 727-733.  show abstract

Morgan, R. Plowright, L. Harrington, K.J. Michael, A. Pandha, H.S. (2010). Targeting HOX and PBX transcription factors in ovarian cancer. Bmc cancer, Vol.10, p. 9.

Comins, C. Spicer, J. Protheroe, A. Roulstone, V. Twigger, K. White, C.M. Vile, R. Melcher, A. Coffey, M.C. Mettinger, K.L. Nuovo, G. Cohn, D.E. Phelps, M. Harrington, K.J. Pandha, H.S. (2010). REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer. Clinical cancer research, Vol.16 (22), pp. 5564-9.

Touchefeu, Y. Harrington, K.J. Galmiche, J.P. Vassaux, G. (2010). Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Alimentary pharmacology & therapeutics, Vol.32 (8), pp. 953-16.

Kazi, R. Dwivedi, R.C. St Rose, S. Roe, J.W. Nutting, C. Rhys-Evans, P.H. Harrington, K.J. (2010). Validation of first speech-specific questionnaire for English-speaking head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Dwivedi, R.C. St Rose, S. Nutting, C. Rhys-Evans, P.H. Harrington, K.J. Kazi, R. (2010). A report on the development and validation of first-ever perceptual speech evaluation tool for head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Karapanagiotou, E.M. Chester, J.D. Pandha, H.S. Gill, G.M. Coffey, M.C. Mettinger, K. Harrington, K.J. (2010). A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN). Journal of clinical oncology, Vol.28 (15).

Harrington, K.J. Berrier, A. Robinson, M. Remenar, E. Housset, M. de Mendoza, F.H. Compton, N. Lau, M. Legenne, P. Kumar, R. (2010). Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN). Journal of clinical oncology, Vol.28 (15).

Pandha, H. Melcher, A. Harrington, K. Vile, R. (2009). Oncolytic Viruses: Time to Compare, Contrast, and Combine?. Molecular therapy, Vol.17 (6), pp. 934-2.

Newbold, K. Castellano, I. Charles-Edwards, E. Mears, D. Sohaib, A. Leach, M. Rhys-Evans, P. Clarke, P. Fisher, C. Harrington, K. Nutting, C. (2009). AN EXPLORATORY STUDY INTO THE ROLE OF DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR PERFUSION COMPUTED TOMOGRAPHY FOR DETECTION OF INTRATUMORAL HYPOXIA IN HEAD-AND-NECK CANCER. International journal of radiation oncology biology physics, Vol.74 (1), pp. 29-9.

Willmon, C. Harrington, K. Kottke, T. Prestwich, R. Melcher, A. Vile, R. (2009). Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Molecular therapy, Vol.17 (10), pp. 1667-10.

Kottke, T. Pulido, J. Thompson, J. Sanchez-Perez, L. Chong, H. Calderwood, S.K. Selby, P. Harrington, K. Strome, S.E. Melcher, A. Vile, R.G. (2009). Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas. Cancer research, Vol.69 (19), pp. 7767-8.

Peerlinck, I. Merron, A. Baril, P. Conchon, S. Martin-Duque, P. Hindorf, C. Burnet, J. Quintanilla, M. Hingorani, M. Iggo, R. Lemoine, N.R. Harrington, K. Vassaux, G. (2009). Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter. Clinical cancer research, Vol.15 (21), pp. 6595-7.

Ismail, M. Morgan, R. Harrington, K. Davies, J. Pandha, H. (2009). Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology, Vol.59 (2), pp. 207-7.

Prestwich, R.J. Errington, F. Diaz, R.M. Pandha, H.S. Harrington, K.J. Melcher, A.A. Vile, R.G. (2009). The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon. Human gene therapy, Vol.20 (10), pp. 1119-14.

Prestwich, R.J. Errington, F. Steele, L.P. Ilett, E.J. Morgan, R.S. Harrington, K.J. Pandha, H.S. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. Journal of immunology, Vol.183 (7), pp. 4312-10.

Pandha, H.S. Heinemann, L. Simpson, G.R. Melcher, A. Prestwich, R. Errington, F. Coffey, M. Harrington, K.J. Morgan, R. (2009). Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma. Clinical cancer research, Vol.15 (19), pp. 6158-9.

Prestwich, R.J. Ilett, E.J. Errington, F. Diaz, R.M. Steele, L.P. Kottke, T. Thompson, J. Galivo, F. Harrington, K.J. Pandha, H.S. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. Clinical cancer research, Vol.15 (13), pp. 4374-8.

Nutting, C.M. van Herpen, C.M. Miah, A.B. Bhide, S.A. Machiels, J.-. Buter, J. Kelly, C. de Raucourt, D. Harrington, K.J. (2009). Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma. Annals of oncology, Vol.20 (7), pp. 1275-5.

Harrington, K.J. El-Hariry, I.A. Holford, C.S. Lusinchi, A. Nutting, C.M. Rosine, D. Tanay, M. Deutsch, E. Matthews, J. D'Ambrosio, C. Turner, S.J. Pandeshwara, J.S. Bourhis, J. (2009). Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of clinical oncology, Vol.27 (7), pp. 1100-8.

Ilett, E.J. Prestwich, R.J. Kottke, T. Errington, F. Thompson, J.M. Harrington, K.J. Pandha, H.S. Coffey, M. Selby, P.J. Vile, R.G. Melcher, A.A. (2009). Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene therapy, Vol.16 (5), pp. 689-11.

Bhide, S.A. Ahmed, M. Rengarajan, V. Powell, C. Miah, A. Newbold, K. Nutting, C.M. Harrington, K.J. (2009). ANEMIA DURING SEQUENTIAL INDUCTION CHEMOTHERAPY AND CHEMORADIATION FOR HEAD AND NECK CANCER: THE IMPACT OF BLOOD TRANSFUSION ON TREATMENT OUTCOME. International journal of radiation oncology biology physics, Vol.73 (2), pp. 391-8.

Agrawal, V.K. Copeland, K.M. Barbachano, Y. Rahim, A. Seth, R. White, C.L. Hingorani, M. Nutting, C.M. Kelly, M. Harris, P. Pandha, H. Melcher, A.A. Vile, R.G. Porter, C. Harrington, K.J. (2009). Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery. Gene therapy, Vol.16 (1), pp. 78-15.

Dandekar, P. Harmer, C. Barbachano, Y. Rhys-Evans, P. Harrington, K. Nutting, C. Newbold, K. (2009). Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis. Int j radiat oncol biol phys, Vol.74 (2), pp. 518-521.  show abstract

Hoskin, P.J. Robinson, M. Slevin, N. Morgan, D. Harrington, K. Gaffney, C. (2009). Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer. Journal of clinical oncology, Vol.27 (34), pp. 5751-6.

Senzer, N.N. Kaufman, H.L. Amatruda, T. Nemunaitis, M. Reid, T. Daniels, G. Gonzalez, R. Glaspy, J. Whitman, E. Harrington, K. Goldsweig, H. Marshall, T. Love, C. Coffin, R. Nemunaitis, J.J. (2009). Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. Journal of clinical oncology, Vol.27 (34), pp. 5763-9.

Manikantan, K. Khode, S. Sayed, S.I. Roe, J. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Dysphagia in head and neck cancer. Cancer treatment reviews, Vol.35 (8), pp. 724-9.

Manikantan, K. Khode, S. Dwivedi, R.C. Palav, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer treatment reviews, Vol.35 (8), pp. 744-10.

Manikantan, K. Sayed, S.I. Syrigos, K.N. Rhys-Evans, P. Nutting, C.M. Harrington, K.J. Kazi, R. (2009). Challenges for the future modifications of the TNM staging system for head and neck cancer: Case for a new computational model?. Cancer treatment reviews, Vol.35 (7), pp. 639-6.

Kazi, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). Significance and prognostic impact of comorbidity in head and neck cancer. Journal of cancer research and therapeutics, Vol.5 (3), pp. 145-3.

Nutting, C.M. Miah, A.B. Bhide, S. Urbano, M.T. Barbachano, Y. Newbold, K.L. Harrington, K.J. (2009). Dose-escalation Chemo-IMRT Improves Locoregional Control Rates in Organ Preservation Treatment of Locally Advanced Laryngeal and Hypopharyngeal Cancers. Clinical oncology, Vol.21 (8), pp. 646-2.

Sayed, S.I. Elmiyeh, B. Rhys-Evans, P. Syrigos, K.N. Nutting, C.M. Harrington, K.J. Kazi, R. (2009). Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions. Cancer treatment reviews, Vol.35 (5), pp. 397-6.

Ismail, M. Bokaee, S. Morgan, R. Davies, J. Harrington, K.J. Pandha, H. (2009). Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy (vol 100, pg 1889, 2009). British journal of cancer, Vol.101 (3), pp. 549-1.

Terpos, E. Kiagia, M. Karapanagiotou, E.M. Charpidou, A. Dilana, K.D. Nasothimiou, E. Harrington, K.J. Polyzos, A. Syrigos, K.N. (2009). The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications. Anticancer research, Vol.29 (5), pp. 1651-7.

Kazi, R.A. Singh, A. Venkitaraman, R. Sayed, S.I. Rhys-Evans, P. Harrington, K.J. (2009). Is electroglottography-based videostroboscopic assessment of post-laryngectomy prosthetic speech useful. Journal of cancer research and therapeutics, Vol.5 (2), pp. 85-8.

Syrigos, K.N. Karachalios, D. Karapanagiotou, E.M. Nutting, C.M. Manolopoulos, L. Harrington, K.J. (2009). Head and neck cancer in the elderly: An overview on the treatment modalities. Cancer treatment reviews, Vol.35 (3), pp. 237-9.

Pandha, H. D'Ambrosio, C. Heenan, S. Hyde, N. Di Palma, S. Nutting, C. Relph, K. Harrington, K. (2009). Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients. Clinical oncology, Vol.21 (4), pp. 363-2.

Plowright, L. Harrington, K.J. Pandha, H.S. Morgan, R. (2009). HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). British journal of cancer, Vol.100 (3), pp. 470-6.

Kazi, R. Kanagalingam, J. Venkitaraman, R. Prasad, V. Clarke, P. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). Electroglottographic and perceptual evaluation of tracheoesophageal speech. J voice, Vol.23 (2), pp. 247-254.  show abstract

Kazi, R. Rhys-Evans, P. Nutting, C.M. Harrington, K.J. (2009). The great debate: stroboscopy vs high- speed imaging for assessment of alaryngeal phonation. J cancer res ther, Vol.5 (2), pp. 121-123.  show abstract

Rogers, S.J. Box, C. Chambers, P. Barbachano, Y. Nutting, C.M. Rhŷs-Evans, P. Workman, P. Harrington, K.J. Eccles, S.A. (2009). Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J pathol, Vol.218 (1), pp. 122-130.  show abstract

Ross, P.J. Teoh, E.M. A'hern, R.P. Rhys-Evans, P.H. Harrington, K.J. Nutting, C.M. Gore, M.E. (2009). Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin oncol (r coll radiol), Vol.21 (4), pp. 311-314.  show abstract

Zaidi, S.H. Huddart, R.A. Harrington, K.J. (2009). Novel targeted radiosensitisers in cancer treatment. Curr drug discov technol, Vol.6 (2), pp. 103-134.  show abstract

Bhide, S.A. Miah, A. Barbachano, Y. Harrington, K.J. Newbold, K. Nutting, C.M. (2009). Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005. Br j oral maxillofac surg, Vol.47 (4), pp. 284-289.  show abstract

Pandha, H. Melcher, A. Harrington, K. Vile, R. (2009). Oncolytic Viruses: Time to Compare, Contrast, and Combine?. Molecular therapy, Vol.17 (6), pp. 934-935.

Clark, C.H. Miles, E.A. Urbano, M.T. Bhide, S.A. Bidmead, A.M. Harrington, K.J. Nutting, C.M. UK PARSPORT Trial Management Group collaborators, (2009). Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br j radiol, Vol.82 (979), pp. 585-594.  show abstract

Dwivedi, R.C. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. Kazi, R. (2009). Future perspectives for health related quality of life (HRQOL) studies in head and neck cancer. G ital med lav ergon, Vol.31 (3 Suppl B), pp. B17-B20.  show abstract

Dwivedi, R.C. Kazi, R.A. Agrawal, N. Nutting, C.M. Clarke, P.M. Kerawala, C.J. Rhys-Evans, P.H. Harrington, K.J. (2009). Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. Cancer treat rev, Vol.35 (5), pp. 417-424.  show abstract

Kazi, R. Nutting, C.M. Rhys-Evans, P. Harrington, K.J. (2009). A short perspective on the surgical restoration of alaryngeal speech. South med j, Vol.102 (8), pp. 838-840.  show abstract

Ismail, M. Bokaee, S. Davies, J. Harrington, K.J. Pandha, H. (2009). Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. British journal of cancer, Vol.100 (12), pp. 1889-7.

Bhide, S.A. Miah, A.B. Harrington, K.J. Newbold, K.L. Nutting, C.M. (2009). Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin oncol (r coll radiol), Vol.21 (10), pp. 737-744.  show abstract

Kottke, T. Thompson, J. Diaz, R.M. Pulido, J. Willmon, C. Coffey, M. Selby, P. Melcher, A. Harrington, K. Vile, R.G. (2009). Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2. Clinical cancer research, Vol.15 (2), pp. 561-9.

Bhide, S. Gulliford, S. A'Hern, R. Hall, E. Newbold, K. Harrington, K. Nutting, C. (2009). Quantitative estimates of the effects of concomitant chemotherapy on acute dysphagia in patients receiving radical treatment for head and neck cancer. J clin oncol, Vol.27 (15_suppl), p. e22134.  show abstract

Karapanagiotou, E. Pandha, H.S. Hall, G. Chester, J. Melcher, A. Coffey, M. de Bono, J. Gore, M.E. Nutting, C.M. Harrington, K.J. (2009). Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers. J clin oncol, Vol.27 (15_suppl), p. e14519.  show abstract

Saunders, M. Anthoney, A. Coffey, M. Mettinger, K. Thompson, B. Melcher, A. Nutting, C.M. Harrington, K. (2009). Results of a phase II study to evaluate the biological effects of intratumoral (ITu) reolysin in combination with low dose radiotherapy (RT) in patients (Pts) with advanced cancers. J clin oncol, Vol.27 (15_suppl), p. e14514.  show abstract

Nutting, C. A'Hern, R. Rogers, M.S. Sydenham, M.A. Adab, F. Harrington, K. Jefferies, S. Scrase, C. Yap, B.K. Hall, E. PARSPORT Trial Management Group, (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). J clin oncol, Vol.27 (15_suppl), p. LBA6006.  show abstract

Harrington, K. Hingorani, M. Tanay, M. Matthews, J. Newbold, K. Renouf, L. Coffin, R.S. McNeish, I. Nutting, C. (2009). Phase I/II dose escalation study of OncoVex(GM-CSF) and chemoradiotherapy (CRT) in untreated stage III/IV squamous cell cancer of the head and neck (SCCHN). J clin oncol, Vol.27 (15_suppl), p. 6018.  show abstract

Nutting, C. A'Hern, R. Rogers, M.S. Sydenham, M.A. Adab, F. Harrington, K. Jefferies, S. Scrase, C. Yap, B.K. Hall, E. PARSPORT Trial Management Group, (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J clin oncol, Vol.27 (18_suppl), p. LBA6006.  show abstract

Rudman, S.M. Comins, C. Mukherji, D. Coffey, M. Mettinger, K. Protheroe, A. Harrington, K.J. Pandha, H. Spicer, J.F. (2009). Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies. J clin oncol, Vol.27 (15_suppl), p. e13524.  show abstract

Ahmed, M. Hansen, V.N. Harrington, K.J. Nutting, C.M. (2009). Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med dosim, Vol.34 (3), pp. 217-224.  show abstract

Qiao, J. Kottke, T. Willmon, C. Galivo, F. Wongthida, P. Diaz, R.M. Thompson, J. Ryno, P. Barber, G.N. Chester, J. Selby, P. Harrington, K. Melcher, A. Vile, R.G. (2008). Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nature medicine, Vol.14 (1), pp. 37-8.

Qiao, J. Wang, H. Kottke, T. White, C. Twigger, K. Diaz, R.M. Thompson, J. Selby, P. de Bono, J. Melcher, A. Pandha, H. Coffey, M. Vile, R. Harrington, K. (2008). Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clinical cancer research, Vol.14 (1), pp. 259-11.

Kazi, R. Venkitaraman, R. Johnson, C. Prasad, V. Clarke, P. Newbold, K. Rhys-Evans, P. Nutting, C. Harrington, K. (2008). Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiotherapy and oncology, Vol.87 (2), pp. 230-7.

Kottke, T. Galivo, F. Wongthida, P. Diaz, R.M. Thompson, J. Jevremovic, D. Barber, G.N. Hall, G. Chester, J. Selby, P. Harrington, K. Melcher, A. Vile, R.G. (2008). Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus. Molecular therapy, Vol.16 (7), pp. 1217-10.

Comins, C. Heinemann, L. Harrington, K. Melcher, A. De Bono, J. Pandha, H. (2008). Reovirus: Viral therapy for cancer 'as nature intended'. Clinical oncology, Vol.20 (7), pp. 548-7.

Kottke, T. Diaz, R.M. Kaluza, K. Pulido, J. Galivo, F. Wongthida, P. Thompson, J. Willmon, C. Barber, G.N. Chester, J. Selby, P. Strome, S. Harrington, K. Melcher, A. Vile, R.G. (2008). Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer. Molecular therapy, Vol.16 (12), pp. 1910-9.

Yap, T.A. Brunetto, A. Pandha, H. Harrington, K. de Bono, J.S. (2008). Reovirus therapy in cancer: has the orphan virus found a home?. Expert opinion on investigational drugs, Vol.17 (12), pp. 1925-11.

Twigger, K. Vidal, L. White, C.L. De Bono, J.S. Bhide, S. Coffey, M. Thompson, B. Vile, R.G. Heinemann, L. Pandha, H.S. Errington, F. Melcher, A.A. Harrington, K.J. (2008). Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin cancer res, Vol.14 (3), pp. 912-923.  show abstract

Kazi, R. Singh, A. Al-Mutairy, A. De Cordova, J. O'Leary, L. Nutting, C. Clarke, P. Evans, P.R. Harrington, K. (2008). Electroglottographic analysis of valved speech following total laryngectomy. Logopedics phoniatrics vocology, Vol.33 (1), pp. 12-10.

Newbold, K.L. Partridge, M. Cook, G. Sharma, B. Rhys-Evans, P. Harrington, K.J. Nutting, C.M. (2008). Evaluation of the role of (18)FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta oncologica, Vol.47 (7), pp. 1229-8.

Singh, A. Kazi, R. Venkitaraman, R. Kapoor, K. Nutting, C. Clarke, P. Rhys, E.P. Harrington, K. (2008). Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report. Clinical otolaryngology, Vol.33 (1), pp. 60-4.

Shears, L. Plowright, L. Harrington, K. Pandha, H.S. Morgan, R. (2008). Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P. Journal of urology, Vol.180 (5), pp. 2196-6.

Vidal, L. Pandha, H.S. Yap, T.A. White, C.L. Twigger, K. Vile, R.G. Melcher, A. Coffey, M. Harrington, K.J. DeBono, J.S. (2008). A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin cancer res, Vol.14 (21), pp. 7127-7137.  show abstract

Hingorani, M. White, C.L. Merron, A. Peerlinck, I. Gore, M.E. Slade, A. Scott, S.D. Nutting, C.M. Pandha, H.S. Melcher, A.A. Vile, R.G. Vassaux, G. Harrington, K.J. (2008). Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors. Cancer research, Vol.68 (23), pp. 9771-8.

Errington, F. White, C.L. Twigger, K.R. Rose, A. Scott, K. Steele, L. Ilett, L.J. Prestwich, R. Pandha, H.S. Coffey, M. Selby, P. Vile, R. Harrington, K.J. Melcher, A.A. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene therapy, Vol.15 (18), pp. 1257-14.

Hingorani, M. White, C.L. Zaidi, S. Merron, A. Peerlinck, I. Gore, M.E. Nutting, C.M. Pandha, H.S. Melcher, A.A. Vile, R.G. Vassaux, G. Harrington, K.J. (2008). Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy. Clinical cancer research, Vol.14 (15), pp. 4915-10.

Prestwich, R.J. Harrington, K.J. Vile, R.G. Melcher, A.A. (2008). Immunotherapeutic potential of oncolytic virotherapy. Lancet oncology, Vol.9 (7), pp. 610-3.

Errington, F. Steele, L. Prestwich, R. Harrington, K.J. Pandha, H.S. Vidal, L. de Bono, J. Selby, P. Coffey, M. Vile, R. Melcher, A. (2008). Reovirus activates human dendritic cells to promote innate antitumor immunity. Journal of immunology, Vol.180 (9), pp. 6018-9.

White, C.L. Menghistu, T. Twigger, K.R. Searle, P.F. Bhide, S.A. Vile, R.G. Melcher, A.A. Pandha, H.S. Harrington, K.J. (2008). Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo. Gene therapy, Vol.15 (6), pp. 424-10.

Kazi, R. Venkitaraman, R. Johnson, C. Prasad, V. Clarke, P. Rhys-Evans, P. Nutting, C.M. Harrington, K.J. (2008). Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Int j radiat oncol biol phys, Vol.70 (2), pp. 344-352.  show abstract

McGough, C. Wedlake, L. Baldwin, C. Hackett, C. Norman, A.R. Blake, P. Harrington, K. Tait, D. Khoo, V. Frost, G. Andreyev, H.J. (2008). Clinical trial: normal diet vs partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy. Aliment pharmacol ther, Vol.27 (11), pp. 1132-1139.  show abstract

Prestwich, R.J. Harrington, K.J. Pandha, H.S. Vile, R.G. Melcher, A.A. Errington, F. (2008). Oncolytic viruses: a novel form of immunotherapy. Expert review of anticancer therapy, Vol.8 (10), pp. 1581-8.

Syrigos, K.N. Katirtzoglou, N. Kotteas, E. Harrington, K. (2008). Adhesion molecules in lung cancer: Implications in the pathogenesis and management. Current pharmaceutical design, Vol.14 (22), pp. 2173-11.

Prestwich, R.J. Errington, F. Harrington, K.J. Pandha, H.S. Selby, P. Melcher, A. (2008). Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?. Clinical medicine. oncology, Vol.2, pp. CMO.S416-CMO.S416.

Lee, B. Cook, G. John, L. Harrington, K. Nutting, C. (2008). Follicular thyroid carcinoma metastasis to the esophagus detected by 18FDG PET/CT. Thyroid, Vol.18 (2), pp. 267-271.  show abstract

Wedlake, L. McGough, C. Hackett, C. Thomas, K. Blake, P. Harrington, K. Tait, D. Khoo, V. Dearnaley, D. Andreyev, H.J. (2008). Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?. Aliment pharmacol ther, Vol.27 (10), pp. 980-987.  show abstract

White, C.L. Twigger, K.R. Vidal, L. De Bono, J.S. Coffey, M. Heinemann, L. Morgan, R. Merrick, A. Errington, F. Vile, R.G. Melcher, A.A. Pandha, H.S. Harrington, K.J. (2008). Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene ther, Vol.15 (12), pp. 911-920.  show abstract

Nutting, C.M. Bhide, S.A. Harrington, K.J. (2008). Treatment of head and neck cancer. New england journal of medicine, Vol.358 (10), pp. 1076-2.

Jankowska, P. Teoh, E.M. Fisher, C. Rhys Evans, P. Nutting, C.M. Harrington, K.J. (2008). Case report Isolated intrathyroid metastasis from undifferentiated and squamous carcinoma of the head and neck: the case for surgery and re-irradiation. Br j radiol, Vol.81 (966), pp. e154-e161.  show abstract

Kazi, R. Johnson, C. Prasad, V. De Cordova, J. Venkitaraman, R. Nutting, C.M. Clarke, P. Evans, P.R. Harrington, K.J. (2008). Quality of life outcome measures following partial glossectomy: assessment using the UW-QOL scale. J cancer res ther, Vol.4 (3), pp. 116-120.  show abstract

Harrington, K.J. Melcher, A. Vassaux, G. Pandha, H.S. Vile, R.G. (2008). Exploiting synergies between radiation and oncolytic viruses. Curr opin mol ther, Vol.10 (4), pp. 362-370.  show abstract

Bhide, S.A. Ahmed, M. Barbachano, Y. Newbold, K. Harrington, K.J. Nutting, C.M. (2008). Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. British journal of cancer, Vol.99 (1), pp. 57-6.

Prestwich, R.J. Errington, F. Ilett, E.J. Morgan, R.S. Scott, K.J. Kottke, T. Thompson, J. Morrison, E.E. Harrington, K.J. Pandha, H.S. Selby, P.J. Vile, R.G. Melcher, A.A. (2008). Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity. Clinical cancer research, Vol.14 (22), pp. 7358-9.

Ahmed, M. Barbachano, Y. Riddell, A.M. Whittaker, S. Newbold, K. Harrington, K. Marais, R. Nutting, C.M. (2008). Preliminary results of an open labelled phase 2 study evaluating the safety and efficacy of sorafenib in metastatic advanced thyroid cancer. Journal of clinical oncology, Vol.26 (15).

Bhide, S.A. Ahmed, M. Powell, C. Newbold, K. Nutting, C.M. Harrington, K. (2008). Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: The impact of blood transfusion on treatment outcome. Journal of clinical oncology, Vol.26 (15).

Kazi, R. Prasad, V. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2008). Questionnaire analysis of swallowing-related outcomes following glossectomy. Orl j otorhinolaryngol relat spec, Vol.70 (3), pp. 151-155.  show abstract

Harrington, K. Jankowska, P. Hingorani, M. (2007). Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer. Clinical oncology, Vol.19 (8), pp. 561-11.

Gaggioli, C. Hooper, S. Hidalgo-Carcedo, C. Grosse, R. Marshall, J.F. Harrington, K. Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature cell biology, Vol.9 (12), pp. 1392-19.

Harris, D. Vidal, L. Melcher, A. Newbold, K. Anthony, A. Karavasilis, V. Agarwal, R. White, C. Twigger, K. Coffey, M. Mettinger, K. Thompson, B. Pandha, H. De-Bono, J. Harrington, K. (2007). A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies. Molecular cancer therapeutics, Vol.6 (12), pp. 3458S-1.

McGough, C. Baidwint, C. Hackett, C. Wedlake, L. Norman, A. Frost, G. Blake, P. Tai, D. Khoo, V. Harrington, K. Andreyev, H.J. (2007). A randomised controlled trial of elemental diet during pelvic radiotherapy. Clinical oncology, Vol.19 (3), pp. S11-1.

Ho, G. Jankowska, P. Perrin, R. Banks, C. Teoh, E. Harrington, K. (2007). Dosimetric problems of radiotherapy to synchronous bilateral acinic cell carcinoma of parotid glands. Clinical oncology, Vol.19 (3), pp. S31-1.

McGough, C. Wedlake, L. Hackett, C. Norman, A. Frost, G. Blake, P. Tait, D. Khoo, V. Harrington, K. Andreyev, H.J. (2007). Use of simple biological markers to monitor gastrointestinal toxicity during pelvic radiotherapy. Clinical oncology, Vol.19 (3), pp. S39-1.

Bhide, S.A. Harrington, K.J. Nutting, C.M. (2007). Otological toxicity after postoperative radiotherapy for parotid tumours. Clin oncol (r coll radiol), Vol.19 (1), pp. 77-82.  show abstract

Nutting, C. Eccles, S. Harrington, K. (2007). MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck. Current enzyme inhibition, Vol.3 (1), pp. 1-12.

Hingorani, M. White, C.L. Agrawal, V.K. Vidal, L. Melcher, A. Harrington, K.J. (2007). Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting?. Curr cancer drug targets, Vol.7 (4), pp. 389-409.  show abstract

Macpherson, I.R. Hooper, S. Serrels, A. McGarry, L. Ozanne, B.W. Harrington, K. Frame, M.C. Sahai, E. Brunton, V.G. (2007). p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism. Oncogene, Vol.26 (36), pp. 5214-15.

Kazi, R. Prasad, V.M. Kanagalingam, J. Georgalas, C. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2007). Analysis of formant frequencies in patients with oral or oropharyngeal cancers treated by glossectomy. Int j lang commun disord, Vol.42 (5), pp. 521-532.  show abstract

Guerrero Urbano, T. Clark, C.H. Hansen, V.N. Adams, E.J. A'Hern, R. Miles, E.A. McNair, H. Bidmead, M. Warrington, A.P. Dearnaley, D.P. Harrington, K.J. Nutting, C.M. (2007). A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother oncol, Vol.85 (1), pp. 36-41.  show abstract

Urbano, T.G. Clark, C.H. Hansen, V.N. Adams, E.J. Miles, E.A. Mc Nair, H. Bidmead, A.M. Warrington, J. Dearnaley, D.P. Harmer, C. Harrington, K.J. Nutting, C.M. (2007). Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother oncol, Vol.85 (1), pp. 58-63.  show abstract

Guerrero Urbano, M.T. Clark, C.H. Kong, C. Miles, E. Dearnaley, D.P. Harrington, K.J. Nutting, C.M. PARSPORT Trial Management Group, (2007). Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. Clin oncol (r coll radiol), Vol.19 (8), pp. 604-613.  show abstract

Jankowska, P.J. Kong, C. Burke, K. Harrington, K.J. Nutting, C. (2007). A systematic study of posterior cervical lymph node irradiation with electrons: Conventional versus customized planning. Radiother oncol, Vol.85 (1), pp. 132-137.  show abstract

Kazi, R. De Cordova, J. Singh, A. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2007). Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales. J voice, Vol.21 (6), pp. 728-734.  show abstract

Kazi, R.A. Prasad, V.M. Kanagalingam, J. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2007). Assessment of the formant frequencies in normal and laryngectomized individuals using linear predictive coding. J voice, Vol.21 (6), pp. 661-668.  show abstract

Harrington, K. (2007). SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene therapy, Vol.14 (24), pp. 1731-1738.  show abstract

Luangdilok, S. Box, C. Patterson, L. Court, W. Harrington, K. Pitkin, L. Rhŷs-Evans, P. O-charoenrat, P. Eccles, S. (2007). Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer res, Vol.67 (16), pp. 7907-7916.  show abstract

Kottke, T. Sanchez-Perez, L. Diaz, R.M. Thompson, J. Chong, H. Harrington, K. Calderwood, S.K. Pulido, J. Georgopoulos, N. Selby, P. Melcher, A. Vile, R. (2007). Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer research, Vol.67 (24), pp. 11970-10.

Pitkin, L. Luangdilok, S. Corbishley, C. Wilson, P.O. Dalton, P. Bray, D. Mady, S. Williamson, P. Odutoye, T. Evans, P.R. Syrigos, K.N. Nutting, C.M. Barbachano, Y. Eccles, S. Harrington, K.J. (2007). Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival. British journal of cancer, Vol.97 (5), pp. 670-8.

Kazi, R. De Cordova, J. Kanagalingam, J. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2007). Quality of life following total laryngectomy: assessment using the UW-QOL scale. Orl j otorhinolaryngol relat spec, Vol.69 (2), pp. 100-106.  show abstract

Kazi, R. Singh, A. De Cordova, J. Al-Mutairy, A. O'Leary, L. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2007). Postlaryngectomy vocal rehabilitation: assessment using a validated questionnaire in 51 patients. Orl j otorhinolaryngol relat spec, Vol.69 (5), pp. 289-294.  show abstract

Bhide, S. Clark, C. Harrington, K. Nutting, C.M. (2007). Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Med dosim, Vol.32 (3), pp. 188-195.  show abstract

Guerrero Urbano, M.T. Henrys, A.J. Adams, E.J. Norman, A.R. Bedford, J.L. Harrington, K.J. Nutting, C.M. Dearnaley, D.P. Tait, D.M. (2006). Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int j radiat oncol biol phys, Vol.65 (3), pp. 907-916.  show abstract

Kazi, R. Singh, A. De Cordova, J. Al-Mutairy, A. Clarke, P. Nutting, C. Rhys-Evans, P. Harrington, K. (2006). Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy. Clinical otolaryngology, Vol.31 (5), pp. 404-7.

Vidal, L. Yap, T.A. White, C.L. Twigger, K. Hingorani, M. Agrawal, V. Kaye, S.B. Harrington, K.J. de Bono, J.S. (2006). Reovirus and other oncolytic viruses for the targeted treatment of cancer. Targeted oncology, Vol.1 (3), pp. 130-21.

Errington, F. Jones, J. Merrick, A. Bateman, A. Harrington, K. Gough, M. O'Donnell, D. Selby, P. Vile, R. Melcher, A. (2006). Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming. Gene therapy, Vol.13 (2), pp. 138-12.

Yap, T.A. Vidal, L. Pandha, H. Spicer, J. Digue, L. Coffey, M. Thompson, B. Kaye, S.B. Harrington, K.J. De-Bono, J.S. (2006). A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer. Ejc supplements, Vol.4 (12), pp. 108-1.

Khalid, U. McGough, C. Hackett, C. Blake, P. Harrington, K.J. Khoo, V.S. Tait, D. Norman, A.R. Andreyev, H.J. (2006). A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int j radiat oncol biol phys, Vol.64 (5), pp. 1432-1441.  show abstract

Kazi, R. Kanagalingam, J. Al-Mutairy, A. Nutting, C.M. Clarke, P. Rhys-Evans, P.H. Harrington, K.J. (2006). Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clinical otolaryngology, Vol.31 (1), pp. 83-1.

Kazi, R. Kiverniti, E. De-Cordova, J. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2006). Quality of life assessment in laryngectomized individuals. Clinical otolaryngology, Vol.31 (1), pp. 83-2.

Nutting, C. Horlock, N. A'Hern, R. Searle, A. Henk, J.M. Rhys-Evans, P. Harrington, K. (2006). Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother oncol, Vol.80 (1), pp. 39-42.  show abstract

Newbold, K. Partridge, M. Cook, G. Sohaib, S.A. Charles-Edwards, E. Rhys-Evans, P. Harrington, K. Nutting, C. (2006). Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. Br j radiol, Vol.79 (943), pp. 554-561.  show abstract

McGough, C. Peacock, N. Hackett, C. Baldwin, C. Norman, A. Frost, G. Blake, P. Tait, D. Khoo, V. Harrington, K. Whelan, K. Andreyev, H.J. (2006). Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study. Clin nutr, Vol.25 (6), pp. 906-912.  show abstract

Kazi, R. Kiverniti, E. Prasad, V. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2006). Multidimensional assessment of female tracheoesophageal prosthetic speech. Clin otolaryngol, Vol.31 (6), pp. 511-517.  show abstract

Kazi, R. Singh, A. Mullan, G.P. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2006). Can objective parameters derived from videofluoroscopic assessment of post-laryngectomy valved speech replace current subjective measures? An e-tool-based analysis. Clin otolaryngol, Vol.31 (6), pp. 518-524.  show abstract

Kazi, R. Prasad, V. Venkitaraman, R. Nutting, C.M. Clarke, P. Rhys-Evans, P. Harrington, K.J. (2006). Questionnaire analysis of the swallowing-related outcomes following total laryngectomy. Clin otolaryngol, Vol.31 (6), pp. 525-530.  show abstract

Kirby, A.M. A'Hern, R.P. D'Ambrosio, C. Tanay, M. Syrigos, K.N. Rogers, S.J. Box, C. Eccles, S.A. Nutting, C.M. Harrington, K.J. (2006). Gefitinib (ZD1839, Iressa(TM)) as palliative treatment in recurrent or metastatic head and neck cancer. British journal of cancer, Vol.94 (5), pp. 631-6.

Errington, F. Bateman, A. Kottke, T. Thompson, J. Harrington, K. Merrick, A. Hatfield, P. Selby, P. Vile, R. Melcher, A. (2006). Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy. Clinical cancer research, Vol.12 (4), pp. 1333-9.

Hu, J.C. Coffin, R.S. Davis, C.J. Graham, N.J. Groves, N. Guest, P.J. Harrington, K.J. James, N.D. Love, C.A. McNeish, I. Medley, L.C. Michael, A. Nutting, C.M. Pandha, H.S. Shorrock, C.A. Simpson, J. Steiner, J. Steven, N.M. Wright, D. Coombes, R.C. (2006). A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin cancer res, Vol.12 (22), pp. 6737-6747.  show abstract

Vidal, L. Pandha, H. Spicer, J. Harrington, K.J. Allen, S. Leader, D. Coffey, M. Thompson, B. Kaye, S. De-Bono, J. (2006). A phase I study of reolysin given intravenously to patients with advanced malignancies. J clin oncol, Vol.24 (18_suppl), p. 3064.  show abstract

Harrington, K.J. Bourhis, J. Nutting, C.M. Rosine, D. Theodosiou, A.M. Gardiner, S. Berger, M.S. Beelen, A.P. Stead, A.G. El-Hariry, I.A. (2006). A phase I, open-label study of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). J clin oncol, Vol.24 (18_suppl), p. 5553.  show abstract

Rogers, S.J. Harrington, K.J. Rhys-Evans, P. O-Charoenrat, P. Eccles, S.A. (2005). Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer metastasis rev, Vol.24 (1), pp. 47-69.  show abstract

Harrington, K. A'Hern, R. Eisen, T. Nutting, C. Gore, M. (2005). Patient selection for palliative whole-brain radiotherapy based on RTOG recursive partitioning analysis. Clinical oncology, Vol.17 (2), pp. 128-1.

Guerrero Urbano, M.T. Clark, C. Hansen, V. Adams, E. Miles, E. McNair, H. Bidmead, M. Dearnley, D. Harrington, K. Nutting, C. (2005). Results of Intensity Modulated Radiotherapy (IMRT) in laryngeal and hypopharyngeal cancer: A dose escalation study. Ejc supplements, Vol.3 (2), pp. 287-1.

Harrington, K.J. Nutting, C.M. Pandha, H.S. (2005). Gene therapy for head and neck cancer. Cancer metastasis rev, Vol.24 (1), pp. 147-164.  show abstract

Newbold, K. Charles-Edwards, E. Sohaib, A. Darcy, J. A'Hern, R. Rhys-Evans, P. Fisher, C. Harrington, K. Nutting, C. (2005). Validation of dynamic contrast enhanced MRI parameters as surrogate markers of hypoxia in squamous cell carcinoma of the head and neck. Ejc supplements, Vol.3 (2), pp. 310-1.

Newbold, K. Sohaib, A. Castellano, I. Mears, D. A'Hern, R. Rhys-Evans, P. Fisher, C. Harrington, K. Nutting, C. (2005). Validation of perfusion computed tomography (CT) parameters as surrogate markers of hypoxia in squamous cell carcinoma of the head and neck. Ejc supplements, Vol.3 (2), pp. 400-1.

Syrigos, K.N. Karapanagiotou, E. Harrington, K.J. (2005). Prostate cancer in the elderly. Anticancer research, Vol.25 (6C), pp. 4527-7.

Hatfield, P. Merrick, A. Harrington, K. Vile, R. Bateman, A. Selby, P. Melcher, A. (2005). Radiation-induced cell death and dendritic cells: Potential for cancer immunotherapy?. Clinical oncology, Vol.17 (1), pp. 1-11.

Mavria, G. Harrington, K.J. Marshall, C.J. Porter, C.D. (2005). In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy. J gene med, Vol.7 (3), pp. 263-275.  show abstract

Harrington, K.J. Michalaki, V.J. Vini, L. Nutting, C.M. Syrigos, K.N. A'hern, R. Harmer, C.L. (2005). Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. Br j radiol, Vol.78 (929), pp. 405-410.  show abstract

Creak, A.L. Harrington, K. Nutting, C. (2005). Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy?. Clin oncol (r coll radiol), Vol.17 (3), pp. 138-147.  show abstract

Rogers, S.J. Box, C. Harrington, K.J. Nutting, C. Rhys-Evans, P. Eccles, S.A. (2005). The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. Expert opin ther targets, Vol.9 (4), pp. 769-790.  show abstract

Olopade, F.A. Norman, A. Blake, P. Dearnaley, D.P. Harrington, K.J. Khoo, V. Tait, D. Hackett, C. Andreyev, H.J. (2005). A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy. Br j cancer, Vol.92 (9), pp. 1663-1670.  show abstract

Humphreys, M. Guerrero Urbano, M.T. Mubata, C. Miles, E. Harrington, K.J. Bidmead, M. Nutting, C.M. (2005). Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. Radiother oncol, Vol.77 (1), pp. 39-44.  show abstract

Kazi, R. Singh, A. De Cordova, J. Clarke, P. Harrington, K. Rhys-Evans, P. (2005). A new self-administered questionnaire to determine patient experience with voice prostheses (Blom-Singer valves). J postgrad med, Vol.51 (4), pp. 253-258.  show abstract

Miles, E.A. Clark, C.H. Urbano, M.T. Bidmead, M. Dearnaley, D.P. Harrington, K.J. A'Hern, R. Nutting, C.M. (2005). The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother oncol, Vol.77 (3), pp. 241-246.  show abstract

Merrick, A. Errington, F. Milward, K. O'Donnell, D. Harrington, K. Bateman, A. Pandha, H. Vile, R. Morrison, E. Selby, P. Melcher, A. (2005). Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. British journal of cancer, Vol.92 (8), pp. 1450-9.

Daniels, G.A. Sanchez-Perez, L. Diaz, R.M. Kottke, T. Thompson, J. Lai, M.Y. Gough, M. Karim, M. Bushell, A. Chong, H. Melcher, A. Harrington, K. Vile, R.G. (2004). A simple method to cure established tumors by inflammatory killing of normal cells. Nature biotechnology, Vol.22 (9), pp. 1125-8.

Syrigos, K.N. Karapanagiotou, E. Harrington, K.J. (2004). The clinical significance of molecular markers to bladder cancer. Hybridoma and hybridomics, Vol.23 (6), pp. 335-8.

Mubashar, M. Harrington, K.J. Chaudhary, K.S. El-Nasir, L. Stamp, G.W. Peters, A.M. (2004). Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines. Acta oncologica, Vol.43 (5), pp. 443-10.

Syrigos, K.N. Harrington, K.J. Karayiannakis, A.J. Baibas, N. Katirtzoglou, N. Roussou, P. (2004). Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma. Anticancer research, Vol.24 (3B), pp. 2027-5.

Clark, C.H. Bidmead, A.M. Mubata, C.D. Harrington, K.J. Nutting, C.M. (2004). Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother oncol, Vol.70 (2), pp. 189-198.  show abstract

Rogers, S.J. Harrington, K.J. Eccles, S.A. Nutting, C.M. (2004). Combination epidermal growth factor receptor inhibition and radical radiotherapy for NSCLC. Expert rev anticancer ther, Vol.4 (4), pp. 569-583.  show abstract

Mendes, R.L. Nutting, C.M. Harrington, K.J. (2004). Residual or recurrent head and neck cancer presenting with nerve root compression affecting the upper limbs. Br j radiol, Vol.77 (920), pp. 688-690.  show abstract

Relph, K. Harrington, K. Pandha, H. (2004). Recent developments and current status of gene therapy using viral vectors in the United Kingdom. British medical journal, Vol.329 (7470), pp. 839-4.

Hess, V. A'Hern, R. Nasiri, N. King, D.M. Blake, P.R. Barton, D.P. Shepherd, J.H. Ind, T. Bridges, J. Harrington, K. Kaye, S.B. Gore, M.E. (2004). Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J clin oncol, Vol.22 (6), pp. 1040-1044.  show abstract

Nutting, C. Harrington, K. (2004). In regards to Dr Glatstein Int J Radiat Oncol Biol Phys 2003;55:561-562, and Dr Amols, Int J Radiat Oncol Biol Phys 2003;56:1507. International journal of radiation oncology biology physics, Vol.58 (4), pp. 1316-2.

Harrington, K.J. Syrigos, K.N. Uster, P.S. Zetter, A. Lewanski, C.R. Gullick, W.J. Vile, R.G. Stewart, J.S. (2004). Targeted radiosensitisation by pegylated liposome-encapsulated 3 ',5 '-O-dipalmitoyl 5-iodo-2 '-deoxyuridine in a head and neck cancer xenograft model. British journal of cancer, Vol.91 (2), pp. 366-8.

Morris, S.L. Low, S.H. A'Hern, R.P. Eisen, T.G. Gore, M.E. Nutting, C.M. Harrington, K.J. (2004). A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. British journal of cancer, Vol.91 (5), pp. 829-5.

Ahmed, A. Jevremovic, D. Suzuki, K. Kottke, T. Thompson, J. Emery, S. Harrington, K. Bateman, A. Vile, R. (2003). Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy. Gene therapy, Vol.10 (19), pp. 1663-9.

Ahmed, A. Thompson, J. Emiliusen, L. Murphy, S. Beauchamp, R.D. Suzuki, K. Alemany, R. Harrington, K. Vile, R.G. (2003). A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. Nature biotechnology, Vol.21 (7), pp. 771-7.

Hall, C.E. Harris, R. A'Hern, R. Archer, D.J. Rhys-Evans, P. Henk, J.M. Harrington, K.J. Nutting, C.M. (2003). Le Fort I osteotomy and low-dose rate Ir192 brachytherapy for treatment of recurrent nasopharyngeal tumours. Radiother oncol, Vol.66 (1), pp. 41-48.  show abstract

Syrigos, K.N. Vile, R.G. Peters, A.M. Harrington, K.J. (2003). Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes after intraperitoneal injection. Acta oncologica, Vol.42 (2), pp. 147-7.

Westbury, C.B. Harrington, K.J. Rhys-Evans, P. Archer, D.J. Searle, A.E. Henk, J.M. Black, C.M. Nutting, C.M. (2003). Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. Postgrad med j, Vol.79 (929), pp. 176-177.  show abstract

Nutting, C.M. Normile, P.S. Bedford, J.L. Harrington, K.J. Webb, S. (2003). A systematic study of techniques for elective cervical nodal irradiation with anterior or opposed anterior and posterior beams. Radiother oncol, Vol.69 (1), pp. 43-51.  show abstract

Michalaki, V.J. Hall, J. Henk, J.M. Nutting, C.M. Harrington, K.J. (2003). Definitive radiotherapy for extramedullary plasmacytomas of the head and neck. Br j radiol, Vol.76 (910), pp. 738-741.  show abstract

Gami, B. Harrington, K. Blake, P. Dearnaley, D. Tait, D. Davies, J. Norman, A.R. Andreyev, H.J. (2003). How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment pharmacol ther, Vol.18 (10), pp. 987-994.  show abstract

Clark, C.H. Miles, E.A. Bidmead, A.M. Mubata, C.D. Harrington, K.J. Nutting, C.M. (2003). In regard to Lee et al , IJROBP 2002;53 : 630-637. International journal of radiation oncology biology physics, Vol.55 (4), pp. 1150-1.

Chester, J. Ruchatz, A. Gough, M. Crittenden, M. Chong, H. Loic-Cosset, L. Diaz, R.M. Harrington, K. Alvarez-Vallina, L. Vile, R. (2002). Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nature biotechnology, Vol.20 (3), pp. 256-8.

Linardakis, E. Bateman, A. Phan, V. Ahmed, A. Gough, M. Olivier, K. Kennedy, R. Errington, F. Harrington, K.J. Melcher, A. Vile, R. (2002). Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer research, Vol.62 (19), pp. 5495-10.

Harrington, K.J. Syrigos, K.N. Vile, R.G. (2002). Uposomally targeted cytotoxic drugs for the treatment of cancer. Journal of pharmacy and pharmacology, Vol.54 (12), pp. 1573-28.

Harrington, K.J. Mubashar, M. Peters, A.M. (2002). Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules - lessons from liposomes and monoclonal antibodies. Quarterly journal of nuclear medicine, Vol.46 (3), pp. 171-10.

Syrigos, K.N. Sitara, D. Georgiou, E. Harrington, K.J. (2002). Cytotoxic therapy of gastroenteropancreatic (GEP) tumors. Anticancer research, Vol.22 (2B), pp. 1311-4.

Harrington, K.J. Bateman, A.R. Melcher, A.A. Ahmed, A. Vile, R.G. (2002). Cancer gene therapy: Part 1 Vector development and regulation of gene expression. Clinical oncology, Vol.14 (1), pp. 3-14.

Harrington, K.J. Melcher, A.A. Bateman, A.R. Ahmed, A. Vile, R.G. (2002). Cancer gene therapy: Part 2 Candidate transgenes and their clinical development. Clinical oncology, Vol.14 (2), pp. 148-22.

Mubashar, M. Harrington, K.J. Chaudhary, K.S. Lalani, E.N. Stamp, G.W. Sinnett, D. Glass, D.M. Peters, A.M. (2002). Tc-99m-Sestamibi Imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer. Journal of nuclear medicine, Vol.43 (4), pp. 519-525.

Harrington, K. (2002). Interactions between ionising radiation and drugs in head and neck cancer - how can we maximize the therapeutic index?. Current opinion in investigational drugs (london, england: 2000), Vol.3 (5), pp. 807-811.

Mendes, R.L. Nutting, C.M. Harrington, K.J. (2002). Managing side effects of radiotherapy in head and neck cancer. Hosp med, Vol.63 (12), pp. 712-717.  show abstract

Harrington, K. Alvarez-Vallina, L. Crittenden, M. Gough, M. Chong, H. Diaz, R.M. Vassaux, G. Lemoine, N. Vile, R. (2002). Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?. Hum gene ther, Vol.13 (11), pp. 1263-1280.  show abstract

Emiliusen, L. Gough, M. Bateman, A. Ahmed, A. Voellmy, R. Chester, J. Diaz, R.M. Harrington, K. Vile, R. (2001). A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. Gene therapy, Vol.8 (13), pp. 987-12.

Harrington, K.J. (2001). Liposomal cancer chemotherapy: current clinical applications and future prospects. Expert opin investig drugs, Vol.10 (6), pp. 1045-1061.

Borri, M. Schmidt, M.A. Powell, C. Koh, D.-. Riddell, A.M. Partridge, M. Bhide, S.A. Nutting, C.M. Harrington, K.J. Newbold, K.L. Leach, M.O. Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data. Plos one, Vol.10 (9), pp. e0138545-e0138545.

Sharma, R.A. Plummer, R. Stock, J.K. Greenhalgh, T.A. Ataman, O. Kelly, S. Clay, R. Adams, R.A. Baird, R.D. Billingham, L. Brown, S.R. Buckland, S. Bulbeck, H. Chalmers, A.J. Clack, G. Cranston, A.N. Damstrup, L. Ferraldeschi, R. Forster, M.D. Golec, J. Hagan, R.M. Hall, E. Hanauske, A.-. Harrington, K.J. Haswell, T. Hawkins, M.A. Illidge, T. Jones, H. Kennedy, A.S. McDonald, F. Melcher, T. O'Connor, J.P. Pollard, J.R. Saunders, M.P. Sebag-Montefiore, D. Smitt, M. Staffurth, J. Stratford, I.J. Wedge, S.R. NCRI CTRad Academia-Pharma Joint Working Group, Clinical development of new drug-radiotherapy combinations. Nat rev clin oncol, Vol.13 (10), pp. 627-642.  show abstract

Bradley, S. Jakes, A. Harrington, K. Pandha, H. Melcher, A. Errington-Mais, F. Applications of coxsackievirus A21 in oncology. Oncolytic virotherapy, , pp. 47-47.

Pandha, H. Simpson, G. Relph, K. Melcher, A. Harrington, K. Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic virotherapy, , pp. 1-1.

Patel, R. Barker, H. Kyula, J. mclaughlin, M. Dillon, M. Schick, U. Hafsi, H. Thompson, A. Khoo, V. Harrington, K. Zaidi, S. An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and oncology, .

Harrington, K. Michielin, O. Malvehy, J. Pezzani Grüter, I. Grove, L. Frauchiger, A.L. Dummer, R. A practical guide to the handling and administration of talimogene laherparepvec in Europe. Oncotargets and therapy, Vol.Volume 10, pp. 3867-3880.

Petkar, I. Bhide, S. Newbold, K. Harrington, K. Nutting, C. Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom. The british journal of radiology, , pp. 20170590-20170590.

Henderson, D. Tree, A. Harrington, K. van As, N. Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer. Medicines, Vol.5 (2), pp. 32-32.

Hafsi, H. Dillon, M. Barker, H. Kyula, J. Schick, U. Paget, J. Smith, H. Pedersen, M. McLaughlin, M. Harrington, K. Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status. Frontiers in oncology, .

Dillon, M. ATR inhibition potentiates the radiation induced inflammatory tumor microenvironment. Clinical cancer research, .

McLaughlin, M. Pedersen, M. Roulstone, V. Bergerhoff, K.F. Smith, H.G. Whittock, H. Kyula, J. Dillon, M.T. Pandha, H. Vile, R. Melcher, A. Harrington, K.J. The PERK inhibitor GSK2606414 enhances reovirus infection in head and neck squamous cell carcinoma via an ATF4-dependent mechanism. Molecular therapy - oncolytics, .

Dunlop, A. Welsh, L. McQuaid, D. Dean, J. Gulliford, S. Hansen, V. Bhide, S. Nutting, C. Harrington, K. Newbold, K. Brain-Sparing Methods for IMRT of Head and Neck Cancer. Plos one, Vol.10 (3), pp. e0120141-e0120141.

Dean, J. Wong, K.H. Nutting, C. Harrington, K.J. Functional data analysis applied to modeling of severe acute mucositis and dysphagia resulting from head and neck radiation therapy. International journal of radiation: oncology - biology - physics, .

Harrington, K. Andtbacka, R. Collichio, F. Downey, G. Chen, L. Szabo, Z. Kaufman, H. Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Oncotargets and therapy, Vol.Volume 9, pp. 7081-7093.

Kerkmeijer, L.G. Fuller, C.D. Verkooijen, H.M. Verheij, M. Choudhury, A. Harrington, K.J. Schultz, C. Sahgal, A. Frank, S.J. Goldwein, J. Brown, K.J. Minsky, B.D. van Vulpen, M. The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Frontiers in oncology, Vol.6.


Book Chapters

Dillon, M. Harrington, K. (2018). Targeting ATR for cancer therapy: ATR-targeted drug candidates. In Pollard, J.Curtin, N. (Eds.), Targeting the DNA Damage Response for Anti-Cancer Therapy. (pp. 99-127). Springer, ISBN: 9783319758367.

Harrington, K.J. Dillon, M.T. (2015). Biologically Targeted Agents in Head and Neck Cancers. Scott-Brown's Otorhinolarnygology and Head and Neck Surgery, Eighth Edition. CRC Press, ISBN: 9781444175899.

Guerrero-Urbano, M.T. Clark, C.H. Bidmead, A.M. Dearnaley, D.P. Harrington, K.J. Nutting, C.M. (2006). IMRT in cancer of the larynx. In Bortfeld, T.Schmidt-Ullrich, R.De Neve, W. (Eds.), Image-guided IMRT. (pp. 335-460). Berlin, Springer Verlag, ISBN: 9783540205111.


Conferences

Fontana, E.Wilkins, A.Patil, Y.Nyamundanda, G.Ragulan, C.Mansfield, D.Kingston, J.Errington-Mais, F.West, N.Bottomley, D.Downs, J.Demaria, S.Harrington, K.J.Melcher, A.Sadanandam, A. (2019). Characterization of chemoradiation-induced changes in immune cells and targets for personalized therapy in locally advanced rectal cancer (LARC)., Journal of Clinical Oncology, Vol.37 (4_suppl), p.589.

Harrington, K. (2019). SP-046 For the motion: This house believes that immunotherapy is going to replace chemotherapy, Radiotherapy and Oncology, Vol.132, p.24.

Jamal, K.Smith, H.Tenev, T.Kyula, J.Roulstone, V.Harrington, K.Meier, P. (2019). Birinapant augments the efficacy of Isolated limb perfusion in an animal model of extremity soft tissue sarcoma, CELL DEATH DISCOVERY, Vol.5.

Jamal, K.Smith, H.Tenev, T.Kyula, J.Roulstone, V.Harrington, K.Meier, P. (2019). Birinapant augments the efficacy of isolated limb perfusion in an animal model of extremity soft tissue sarcoma, CELL DEATH DISCOVERY, Vol.5.

Ng-Cheng-Hin, B.McQuaid, D.Dunlop, A.Court, S.Petkar, I.Nutting, C.Harrington, K.Bhide, S.Newbold, K. (2019). EP-1181 Structure delineation using a deformable image registration-based contour propagation in HNC, Radiotherapy and Oncology, Vol.133, p.S654.

Harrington, K. (2019). SP-0215 How to combine checkpoint inhibitors with radiotherapy?, Radiotherapy and Oncology, Vol.133, p.S112.

Thomas, S.Juncheria, L.Roulstone, V.Kyula, J.N.Kaufman, H.L.Harrington, K.J.Coffin, R.S. (2019). Development & characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1, CANCER RESEARCH, Vol.79 (13).

Emancipator, K.Huang, L.Juco, J.Aurora-Garg, D.Bal, T.Cohen, E.E.Harrington, K.Soulieres, D.Le Tourneau, C.Licitra, L.Burtness, B.Swaby, R. (2019). Evaluation of programmed death ligand-1 expression and efficacy outcomes in patients with squamous cell carcinoma of the head and neck from KEYNOTE-040 using two scoring techniques, VIRCHOWS ARCHIV, Vol.475, p.S26.

Kramer-Marek, G.Maczynska, J.Raes, F.Malarz, K.Da Pieve, C.de Mezer, M.Niedbala, M.Harrington, K.J.Kaspera, W. (2019). Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy, ANNALS OF ONCOLOGY, Vol.30.

Hoebart, J.Da Pieve, C.Raes, F.Ciobota, D.M.Smith, G.Melcher, A.Harrington, K.J.Kramer-Marek, G. (2019). Is [Zr-89]PD-L1 a useful tool to capture an immune response to oncolytic virotherapy?, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vol.46 (SUPPL 1), pp.S192-S193.

Middleton, M.R.Harrington, K.Ross, M.Ohrling, K.Radcliffe, H.-.Collichio, F. (2019). Efficacy of talimogene laherparepvec (T-VEC) in melanoma patients (pts) with locoregional (LR) recurrence, including in-transit metastases (ITM): Subgroup analysis of the phase III OPTiM study, ANNALS OF ONCOLOGY, Vol.30.

Cohen, E.Harrington, K.Soulieres, D.Le Tourneau, C.Licitra, L.F.Burtness, B.Bal, T.Juco, J.Aurora-Garg, D.Huang, L.Swaby, R.F.Emancipator, K. (2019). Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040, ANNALS OF ONCOLOGY, Vol.30.

Dillon, M.Guevara, J.Mohammed, K.Smith, S.A.Dean, E.McLellan, L.Boylan, Z.Spicer, J.Forster, M.D.Harrington, K.J. (2019). A phase I study of ATR inhibitor, AZD6738, as monotherapy in advanced solid tumours (PATRIOT part A, B), ANNALS OF ONCOLOGY, Vol.30, pp.165-+.

Quinn, C.Garrison, L.P.Briggs, A.Pownell, A.Atkins, M.de Pouvourville, G.Harrington, K.Ascierto, P.A.McEwan, P.Doan, J.Wagner, S.Borrill, J.Wu, E. (2019). A MULTI-STAKEHOLDER PERSPECTIVE ON THE CHALLENGES IN DEMONSTRATING THE LONG-TERM BENEFIT OF CANCER IMMUNOTHERAPY, VALUE IN HEALTH, Vol.22, p.S446.

Harrington, K.J.Cohen, E.E.Soulieres, D.Dinis, J.Licitra, L.F.Ahn, M.-.Soria, A.Machiels, J.-.Mach, N.Mehra, R.Burtness, B.Lin, J.Cheng, J.D.Swaby, R.F.Le Tourneau, C. (2019). Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state., Journal of Clinical Oncology, Vol.37 (15_suppl), p.6026.

Middleton, M.R.Sacco, J.J.Merchan, J.R.Curti, B.D.Vanderwalde, A.M.Olsson-Brown, A.C.Aroldi, F.Fotiadis, N.Baum, S.Coffin, R.S.Kaufman, H.Harrington, K.J. (2019). An open label, multicenter, phase I/II study of RP1 as a single agent and in combination with PD1 blockade in patients with solid tumors., Journal of Clinical Oncology, Vol.37 (15_suppl), p.TPS2671.

Rischin, D.Harrington, K.J.Greil, R.Soulieres, D.Tahara, M.de Castro, G.Psyrri, A.Baste, N.Neupane, P.C.Bratland, A.Fuereder, T.Hughes, B.G.Mesia, R.Ngamphaiboon, N.Rordorf, T.Wan Ishak, W.Z.Zhang, Y.Jin, F.Gumuscu, B.Burtness, B. (2019). Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)., Journal of Clinical Oncology, Vol.37 (15_suppl), p.6000.

Milhem, M.M.Harrington, K.J.Collichio, F.A.Amatruda, T.Chesney, J.A.Agarwala, S.S.Bhatta, S.Yi, M.Middleton, M.R.Ross, M.I.Puzanov, I. (2019). Progression-free survival (PFS) in unresectable melanoma patients (pts) treated with talimogene laherparepvec (T-VEC) versus granulocyte macrophage colony-stimulating factor (GM-CSF) in OPTiM., Journal of Clinical Oncology, Vol.37 (15_suppl), p.9524.

Soulieres, D.Cohen, E.Tourneau, C.L.Dinis, J.Licitra, L.Ahn, M.-.Soria, A.Machiels, J.-.Mach, N.Mehra, R.Burtness, B.Zhang, P.Cheng, J.Swaby, R.Harrington, K.J. (2018). Abstract CT115: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma, Presented at Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL, Clinical Trials, .

Berges, A.Cheung, S.Y.Pierce, A.J.Dean, E.Felicetti, B.Standifer, N.Smith, S.Yates, J.Lau, A.Stephens, C.Krebs, M.Harrington, K.Hollingsworth, S.J. (2018). Abstract CT118: PK-Biomarker-Safety modelling aids choice of recommended Phase II dose and schedule for AZD6738 (ATR inhibitor), Presented at Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL, Clinical Trials, .

Ferris, R.L.Blumenschein, G.R.Fayette, J.Guigay, J.Colevas, A.D.Licitra, L.Harrington, K.J.Kasper, S.Vokes, E.E.Even, C.Worden, F.Saba, N.F.Docampo, L.C.Haddad, R.Rordorf, T.Kiyota, N.Tahara, M.Lynch, M.Jayaprakash, V.Li, L.Gillison, M.L. (2018). Abstract CT116: Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141, Presented at Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL, Clinical Trials, .

Cohen, E.E.Rischin, D.Pfister, D.G.Vermorken, J.B.Zhao, Y.Gowda, H.Ge, J.Y.Jin, F.Harrington, K.J. (2018). A phase 3, randomized, open-label study of epacadostat plus pembrolizumab, pembrolizumab monotherapy, and the EXTREME regimen as first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma (R/M SCCHN): ECHO-304/KEYNOTE-669., Journal of Clinical Oncology, Vol.36 (15_suppl), p.TPS6090.

Ferris, R.L.Concha-Benavente, F.Blumenschein, G.R.Harrington, K.J.Fayette, J.Colevas, A.D.Licitra, L.F.Kasper, S.Even, C.Gillison, M.L.Worden, F.Saba, N.F.Haddad, R.I.Tahara, M.Hasegawa, Y.Yen, C.-.Lynch, M.J.Monga, M.Geese, W.J.Vokes, E.E. (2017). Characterization of potential predictive biomarkers of response to nivolumab in CheckMate-141 in patients with squamous cell carcinoma of the head and neck (SCCHN)., Journal of Clinical Oncology, Vol.35 (7_suppl), p.5.

Kordbacheh, T.Chan, C.Bossons, A.Franks, K.McDonald, F.Forster, M.Mendes, R.Quezada, S.Dovedi, S.Ralph, C.Popat, S.Harrington, K.Melcher, A.Popple, A.Illidge, T.Faivre-Finn, C. (2017). PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC), LUNG CANCER, Vol.103, pp.S75-S76.

Kordbacheh, T.Chan, C.Faivre-Finn, C.Franks, K.McDonald, F.Forster, M.Mendes, R.Quezade, S.Dovedi, S.Ralph, C.Popat, S.Harrington, K.Melcher, A.Popple, A.Illidge, T. (2017). PD-RAD:A translational study investigating PD-L1 expression after radiotherapy for non-small cell lung cancer (NSCLC), LUNG CANCER, Vol.103, pp.S78-S79.

Concha-Benavente, F.Gillison, M.L.Blumenschein, G.R.Harrington, K.Fayette, J.Colevas, A.D.Licitra, L.Kasper, S.Even, C.Worden, F.P.Saba, N.F.Haddad, R.I.Tahara, M.Hasegawa, Y.Yen, C.-.Lynch, M.J.Monga, M.Geese, W.J.Vokes, E.E.Ferris, R.L. (2017). Characterization of potential predictive biomarkers of response to nivolumab in CheckMate 141 in patients with squamous cell carcinoma of the head and neck (SCCHN)., Journal of Clinical Oncology, Vol.35 (15_suppl), p.6050.

Andtbacka, R.Kaufman, H.Collichio, F.Amatruda, T.Nemunaitis, J.Chesney, J.Puzanov, I.Harrington, K.Zhang, Y.Chen, L.Shilkrut, M.Ross, M. (2016). Durable Complete Responses (CRs) in Patients (pts) with Stage IIIB-IV Melanoma Treated with Talimogene Laherparepvec (T-VEC) in OPTiM, ANNALS OF SURGICAL ONCOLOGY, Vol.23, pp.S31-S32.

Wong, K.H.Welsh, L.Mcquaid, D.Dunlop, A.Murray, I.Du, Y.Chua, S.Panek, R.Riddell, A.Koh, D.M.Bhide, S.Nutting, C.Harrington, K.Newbold, K. (2016). Metabolic Tumor Volume Changes Measured by 18F-FDG-PET/CT After 1 Cycle of Induction Chemotherapy Is an Early Predictor of Radical Chemoradiation Therapy Outcome in Head and Neck Squamous Cell Carcinoma, International Journal of Radiation Oncology*Biology*Physics, Vol.94 (4), pp.920-921.

Patel, A.Jhanji, S.Pavlu, J.Laffan, M.Ethell, M.Bradshaw, A.Olavarria, E.Harrington, K.Apperley, J.Brett, S. (2016). Mesenchymal stromal stem cell (MSC) immunotherapy for experimental septic shock: systematic review and meta-analysis with trial sequential analysis of mortality, BONE MARROW TRANSPLANTATION, Vol.51, p.S129.

Pandha, H.S.Annels, N.E.Simpson, G.Mostafid, H.Harrington, K.J.Melcher, A.Grose, M.Davies, B.Au, G.G.Karpathy, R.Shafren, D. (2016). Phase I/II canon study: Oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21., Journal of Clinical Oncology, Vol.34 (15_suppl), p.e16016.

Ferris, R.L.Blumenschein, G.R.Fayette, J.Guigay, J.Colevas, A.D.Licitra, L.F.Harrington, K.J.Kasper, S.Vokes, E.E.Even, C.Worden, F.P.Haddad, R.I.Kiyota, N.Tahara, M.Monga, M.Lynch, M.J.Geese, W.J.Kopit, J.Shaw, J.W.Gillison, M.L. (2016). Further evaluations of nivolumab (nivo) versus investigator’s choice (IC) chemotherapy for recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CheckMate 141., Journal of Clinical Oncology, Vol.34 (15_suppl), p.6009.

Pandha, H.S.Harrington, K.J.Ralph, C.Melcher, A.Mansfield, D.Grose, M.Davies, B.Karpathy, R.Shafren, D. (2016). Phase I STORM study (KEYNOTE 200): Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients., Journal of Clinical Oncology, Vol.34 (15_suppl), p.TPS3108.

Forster, M.D.Mendes, R.Harrington, K.J.Guerrero Urbano, T.Baines, H.Spanswick, V.J.Ensell, L.Hartley, J.A.Adeleke, S.Gougis, P.Leader, D.McDowell, C.Lopes, A.Teague, J.Forsyth, S.Beare, S. (2016). ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck., Journal of Clinical Oncology, Vol.34 (15_suppl), p.TPS6108.

Rajani, K.Parrish, C.Shim, K.Ilett, L.Errington-Mais, F.Thompson, J.Kottke, T.Maria-Diaz, R.Selby, P.Pandha, H.Harrington, K.Melcher, A.Coffey, M.Zaidi, S.Vile, R. (2015). Abstract 1360: Combination therapy of reovirus and PD-1 blockade effectively establishes tumor control via innate and adaptive immune responses, Presented at Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA, Immunology, .

Pandha, H.Harrington, K.Ralph, C.Melcher, A.Shafren, D.R. (2015). Abstract CT205: Intravenous delivery of a novel oncolytic immunotherapy agent, CAVATAK, in advanced cancer patients, Presented at Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA, Clinical Trials, .

Rajani, K.Shim, K.Parrish, C.Ilett, L.Kottke, T.Pulido, J.Thompson, J.Pandha, H.Harrington, K.Melcher, A.Errington, F.Diaz, R.Coffey, M.Zaidi, S.Vile, R. (2015). 69. Combination Therapy of Reovirus and PD-1 Blockade Effectively Establishes Tumor Control Via Innate and Adaptive Immune Responses, Molecular Therapy, Vol.23, p.S30.

Andtbacka, R.H.Kaufman, H.Collichio, F.Amatruda, T.Nemunaitis, J.Chesney, J.Puzanov, I.Harrington, K.Zhang, Y.Chen, L.Shilkrut, M.Ross, M. (2015). Durable complete responses (CR) in patients (pts) with stage IIIB-IV melanoma treated with talimogene laherparepvec (T-VEC) in OPTiM, EUROPEAN JOURNAL OF CANCER, Vol.51, p.S676.

Burley, T.Martins, C.D.Da Pieve, C.Paul, R.L.Ciobota, D.M.Smith, G.Harrington, K.Kramer-Marek, G. (2015). 89Zr-Affibody for specific detection of EGFR expression in HNSCC, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vol.42, p.S247.

Gujral, D.M.Long, M.Roe, J.Harrington, K.Nutting, C. (2015). Definition of Planning Target Volume Margins for Carotid Sparing Intensity Modulated Radiation Therapy for Early Glottis Cancer, International Journal of Radiation Oncology*Biology*Physics, Vol.93 (3), p.E314.

Harrington, K.Machiels, J.-.Shin, S.W.Cohen, E.Burtness, B.Gause, C.Swift, A.Swaby, R.Le Tourneau, C. (2015). Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: methodology of phase 3 randomized trial, ANNALS OF ONCOLOGY, Vol.26, pp.5-6.

Machiels, J.-.Shin, S.W.Cohen, E.Harrington, K.Burtness, B.Gause, C.Swift, A.Swaby, R.Le Tourneau, C. (2015). Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: Methodology of phase 3 randomized trial, ANNALS OF ONCOLOGY, Vol.26, pp.101-102.

Yen, C.J.Klochikhin, A.Cohen, E.Vermorken, J.Harrington, K.Tahara, M.Ge, Y.Geib, J.Jin, F.Burtness, B. (2015). Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048, ANNALS OF ONCOLOGY, Vol.26, p.101.

Cohen, E.E.Machiels, J.-.Harrington, K.J.Burtness, B.Shin, S.W.Gause, C.K.Swift, A.M.Brown, H.Perrone, A.M.Cheng, J.D.Swaby, R.F.Le Tourneau, C. (2015). KEYNOTE-040: A phase III randomized trial of pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer., Journal of Clinical Oncology, Vol.33 (15_suppl), p.TPS6084.

Jebar, A.Bentham, M.Errington-Mais, F.Scott, K.Peckham-Cooper, A.Dave, R.Toogood, G.Swinson, D.Ralph, C.Anthoney, A.Coffey, M.Harrington, K.Pandha, H.Vile, R.Selby, P.Melcher, A.Griffin, S. (2014). Combined anti-viral and anti-tumour therapy for virus-associated liver cancer, HUMAN GENE THERAPY, Vol.25 (12), p.A27.

Kyula, J.Roulstone, V.Elliot, R.McEntee, G.Lord, C.Coffey, M.Ashworth, A.Harrington, K. (2014). Exploiting oncolytic viruses with the use of pharmacological screens to find potential combination therapies in melanoma, HUMAN GENE THERAPY, Vol.25 (12), p.A15.

Bolton, G.C.Simpson, G.R.Coffey, M.Harrington, K.Morgan, R.Annels, N.Launchbury, F.A.Ajaz, M.Pandha, H. (2014). Resistance to Oncolytic Reovirus is associated with high expression of Yes-Associated Protein-1 (YAP-1) in Head and Neck Cancer, HUMAN GENE THERAPY, Vol.25 (12), pp.A12-A13.

McEntee, G.Kyula, J.Roulstone, V.Coffey, M.Harrington, K.J. (2014). In vitro study of oncolytic reovirus type 3 (Dearing) and radiation combination therapy in melanoma, HUMAN GENE THERAPY, Vol.25 (12), p.A14.

Simpson, G.R.Ajaz, M.Launchbury, F.A.Bolton, G.Melcher, A.A.Harrington, K.J.Au, G.G.Shafren, D.R.Pandha, H.S. (2014). Major synergy between Coxsackievirus A21 (CAVATAK (TM)) and radiotherapy or chemotherapy in bladder cancer, HUMAN GENE THERAPY, Vol.25 (12), p.A13.

Ilett, E.Kottke, T.Donnelly, O.Thompson, J.Willmon, C.Diaz, R.Zaidi, S.Coffey, M.Selby, P.Harrington, K.Pandha, H.Melcher, A.Vile, R. (2014). Direct, Cytokine-Conditioned, In Vivo Cell Loading for Systemic Delivery of Oncolytic Viruses, MOLECULAR THERAPY, Vol.22, p.S245.

Zaidi, S.Blanchard, M.Shim, K.Ilett, E.Kottke, T.Thompson, J.Celis, E.Pandha, H.Selby, P.Melcher, A.Harrington, K.Vile, R. (2014). Acquisition of Mutated BRAF Is as a Major Effector of Melanoma Recurrence Which Can Be Targeted By Immuno- or Chemo-Therapy, MOLECULAR THERAPY, Vol.22, p.S245.

Simpson, G.R.Annels, N.Ajaz, M.Launchbury, F.Bolton, G.Melcher, A.A.Harrington, K.J.Au, G.Shafren, D.Pandha, H. (2014). Major synergy between Coxsackievirus A21 (CAVATAK (TM)) and radiotherapy or chemotherapy in bladder cancer, EUROPEAN JOURNAL OF CANCER, Vol.50, pp.41-42.

Jebar, A.West, E.Scott, K.Thomson, S.Corns, R.Coffey, M.C.Rose, A.Nuovo, G.Ryan, M.Errington-Mais, F.Ralph, C.Twelves, C.Griffin, S.Harrington, K.J.Pandha, H.S.Donnely, O.Selby, P.J.Vile, R.Short, S.Melcher, A. (2014). Oncolytic wild-type reovirus infection in brain tumors following intravenous administration in patients., Journal of Clinical Oncology, Vol.32 (15_suppl), p.3104.

Harrington, K.J.Temam, S.D'Cruz, A.Jain, M.M.D'Onofrio, I.Manikhas, G.M.Horvai, G.Sun, Y.Dietzsch, S.Dubinsky, P.Holeckova, P.Mehanna, H.El-Hariry, I.Franklin, N.Biswas-Baldwin, N.Legenne, P.Wissel, P.S.Netherway, T.Santillana, S.Bourhis, J. (2014). Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN)., Journal of Clinical Oncology, Vol.32 (15_suppl), p.6005.

Gujral, D.M.Shah, B.N.Chahal, N.S.Bhattacharyya, S.Schick, U.Senior, R.Harrington, K.J.Nutting, C.M. (2013). Arterial Stiffness and Elasticity as Markers of Radiation-Induced Atherosclerosis, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Vol.87 (2), p.S194.

Boisgerault, N.Pulido, J.Kottke, T.Donnelly, O.Celis, E.Thompson, J.Diaz, R.Harrington, K.Pandha, H.Selby, P.Melcher, A.Vile, R. (2013). Tumor Recurrences Share Immunogenic Antigens across Both Tumor Types and Primary Treatments Which Can Be Therapeutically Targeted with VSV-cDNA Libraries, MOLECULAR THERAPY, Vol.21, p.S152.

Kottke, T.Donnelly, O.Ilett, E.Thompson, J.Diaz, R.Coffey, M.Selby, P.Pandha, H.Harrington, K.Melcher, A.Vile, R. (2013). In Vivo Expansion of a Recipient Population of Cell Carriers Allows for Highly Effective Systemic Delivery of Oncolytic Reovirus Even in the Presence of Neutralizing Antibody, MOLECULAR THERAPY, Vol.21, p.S7.

Kottke, T.Donnelly, O.Boisgerault, N.Diaz, R.Rommelfanger-Konkol, D.Pulido, J.Thompson, J.Mukhopadhyay, D.Knutson, K.Behrens, M.Kaspar, R.Coffey, M.Selby, P.Harrington, K.Melcher, A.Pandha, H.Vile, R. (2013). Tumor Relapse Is Associated with an Innate Immune Resistant Phenotype across Tumor and Treatment Types Which Can Be Targeted with Rational Second Line Therapies, MOLECULAR THERAPY, Vol.21, p.S249.

Box, C.Baker, L.C.Beloueche-Babari, M.Rogers, S.J.Box, G.M.Harrington, K.J.Leach, M.O.Robinson, S.P.Eccles, S.A. (2013). 2D, 3D and in vivo models of head and neck cancer identify novel correlates of resistance to epidermal growth factor receptor tyrosine kinase inhibitors, EUROPEAN JOURNAL OF CANCER, Vol.49, p.S772.

Gujral, D.M.Shah, B.N.Chahal, N.S.Bhattacharyya, S.Schick, U.Senior, R.Harrington, K.J.Nutting, C.M. (2013). Speckle tracking to measure arterial strain as a marker of radiation-induced atherosclerosis, EUROPEAN JOURNAL OF CANCER, Vol.49, pp.S760-S761.

Wilkinson, M.Pencavel, T.Yu, Y.Harrington, K.Hayes, A.Szalay, A. (2013). Oncolytic vaccinia virus combined with standard TNF/Melphalan chemotherapy delays tumour growth and prolongs survival in a rat sarcoma isolated limb perfusion model, EUROPEAN JOURNAL OF CANCER, Vol.49, pp.S145-S146.

Kaufman, H.Andtbacka, R.H.Harrington, K.Collichio, F.Amatruda, T.Senzer, N.Chesney, J.Delman, K.A.VanderWalde, A.Coffin, R. (2013). Secondary endpoints from OPTiM: A multicenter, randomized phase 3 trial of talimogene laherparepvec vs GM-CSF for the treatment of unresected stage IIIB/C and IV melanoma, EUROPEAN JOURNAL OF CANCER, Vol.49, pp.S865-S866.

Otter, S.Gulliford, S.Schick, U.Zaidi, S.Newbold, K.Nutting, C.Harrington, K.Bhide, S. (2012). Atlas-based Dose Volume Modeling of Individual Patient Dose-distribution (Oral and Pharyngeal Mucosa) to Predict the Risk of Acute Grade 3 Oral and Pharyngeal Mucositis, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Vol.84 (3), pp.S60-S61.

Kottke, T.Donnelly, O.Boisgerault, N.Diaz, R.Thompson, J.Chester, J.Pandha, H.Harrington, K.Melcher, A.Vile, R. (2012). Characterization of the Mechanisms of Tumor Dormancy and Recurrence Following Front Line Immuno-, Viro- or Suicide Gene-, Therapy, MOLECULAR THERAPY, Vol.20, p.S268.

Touchefeu, Y.Khan, A.Roulstone, V.Harrington, K.J. (2012). COMBINING EXTERNAL BEAM RADIOTHERAPY WITH MEASLES-VIRUS ONCOLYTIC THERAPY AND SAR-020106, A NOVEL RADIOSENSITIZER, IN HEAD AND NECK CANCER MODELS, ANNALS OF ONCOLOGY, Vol.23, p.537.

Harrington, K.J. (2012). PARP INHIBITORS AND OTHER STRATEGIES IN CHEMORADIATION, ANNALS OF ONCOLOGY, Vol.23, pp.42-43.

Pencavel, T.Harrington, K.Hayes, A. (2011). Oncolytic virotherapy in an in vivo model of isolated limb perfusion for advanced extremity sarcoma, Presented at Annual Meeting of the Society-of-Academic-and-Research-Surgery, Royal Coll Surgery, Dublin, IRELAND. BRITISH JOURNAL OF SURGERY, Vol.98, pp.14-2.

Harrington, K. (2011). New Targeted Drugs - Biological Agents, Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S22-1.

Powell, C.Borri, M.Koh, D.M.Riddell, A.Schmidt, M.Partridge, M.Harrington, K.Nutting, C.Bhide, S.Newbold, K. (2011). The Role of Functional Imaging in Characterising Disease Response in Patients Undergoing Chemoradiation for Head and Neck Cancer (HNC), Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S556-2.

Richards, T.M.Bhide, S.A.Miah, A.B.Schick, U.Gujral, D.M.Newbold, K.Harrington, K.J.Nutting, C.M. (2011). Phase 2 Trial of Total Mucosal and Bilateral Neck Intensity Modulated Radiotherapy in Squamous Cell Cancer of Unknown Primary, Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S559-1.

Zaidi, S.H.Miah, A.B.Bhide, S.A.Urbano, M.T.Clark, C.Newbold, K.Harrington, K.J.Nutting, C.M. (2011). Radiotherapy for High-risk Thyroid Malignancies - Report of Acute Toxicities of a Phase I Sequential Cohort Dose-escalation IMRT Study, Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S560-1.

Karapanagiotou, E.Pencavel, T.Twigger, K.Mansfield, D.Roulstone, V.Syrigos, K.Harrington, K. (2011). Enhanced in Vitro and in Vivo Cytotoxicity of Combined Vaccinia Virus Strain GLV-1h68 and Chemotherapy in Melanoma, Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S659-1.

Pencavel, T.Seth, R.Mansfield, D.Khan, A.Hayes, A.Harrington, K. (2011). Administration of Oncolytic Vaccinia Virus GLV1h68 by Isolated Limb Perfusion to an Immunocompetent Rat Model of Advanced Extremity Sarcoma, Presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, SWEDEN. EUROPEAN JOURNAL OF CANCER, Vol.47, pp.S663-1.

Powell, C.Schmidt, M.Borri, M.Koh, D.M.Riddeil, A.Nutting, C.Harrington, K.Bhide, S.Newbold, K. (2011). INVESTIGATING FUNCTIONAL MRI AS A SURROGATE MARKER OF EARLY RESPONSE TO CHEMORADIATION IN HEAD AND NECK CANCER, Radiotherapy and Oncology, Vol.98, p.S45.

Buettner, F.Mian, A.Gulliford, S.Harrington, K.Webb, S.Partridge, M.Nutting, C. (2011). A NOVEL APPROACH TO MODELLING XEROSTOMIA BASED ON THE SHAPE OF THE 3D DOSE-DISTRIBUTION AND CLINICAL FACTORS, Radiotherapy and Oncology, Vol.98, p.S35.

Miah, A.Guiliford, S.Bhide, S.Harrington, K.Newbold, K.Nutting, C. (2011). A COMPARISON OF WHOLE PAROTID AND PARTIAL PAROTID GLAND SPARING IMRT TECHNIQUES IN HEAD AND NECK CANCERS, Radiotherapy and Oncology, Vol.98, p.S43.

Wilkins, A.Newboid, K.Harrington, K.Nutting, C.Bhide, S. (2011). ACUTE TOXICITY AND EFFICACY OF CHEMO-RADIATION USING CARBOPLATIN COMPARED WITH CISPLATIN IN HEAD AND NECK CANCER, Radiotherapy and Oncology, Vol.98, p.S35.

Gulliford, S.Miah, A.Brennan, S.Partridge, M.Harrington, K.Nutting, C. (2011). DOSE-VOLUME ATLASES OF COMPLICATION INCIDENCE FOR ACUTE FATIGUE: DATA FROM THE PARSPORT TRIAL, Radiotherapy and Oncology, Vol.98, p.S28.

Bhide, S.Gulliford, S.Schick, U.Newbold, K.Harrington, K.Nutting, C. (2011). CLINICAL RADIOBIOLOGY OF THE ORAL AND PHARYNGEAL MUCOSA IN PATIENTS RECEIVING INDUCTION CHEMOTHERAPY FOLLOWED BY, CONCOMITANT CHEMOTHERAPY AND IMRT FOR HEAD AND NECK CANCER, Radiotherapy and Oncology, Vol.98, p.S27.

Miah, A.Gulliford, S.Bhide, S.Newbold, K.Harrington, K.Nutting, C. (2011). DOSE VOLUME HISTOGRAM ATLASES OF XEROSTOMIA INCIDENCE: AN ALTERNATIVE PREDICTOR OF RECOVERY OF SALIVARY FUNCTION, RADIOTHERAPY AND ONCOLOGY, Vol.98, pp.S27-S28.

Buettner, F.Miah, A.Gulliford, S.Harrington, K.Webb, S.Partridge, M.Nutting, C. (2011). A NOVEL DOSE-RESPONSE MODEL FOR XEROSTOMIA ALLOWING FOR REGIONAL VARIATIONS IN RADIO-SENSITIVITY OF THE PAROTID, Radiotherapy and Oncology, Vol.98, p.S6.

Miah, A.Gulliford, S.Harrington, K.Bhide, S.Newbold, K.Nutting, C. (2011). 519 oral RECOVERY OF SALIVARY GLAND TOXICITY: CONTRALATERAL PAROTID GLAND (PG) VERSUS BILATERAL SUPERFICIAL LOBES PAROTID SPARING IMRT (PARSPORT VERSUS PARSPORT II), Radiotherapy and Oncology, Vol.99, p.S211.

Gulliford, S.Miah, A.Brennan, S.Partridge, M.Harrington, K.Nutting, C. (2011). 1148 poster THE DOSE-VOLUME RESPONSE OF POSTERIOR FOSSA AND BRAINSTEM WITH RESPECT TO ACUTE FATIGUE, Radiotherapy and Oncology, Vol.99, p.S428.

Zimmermann, M.Box, C.Rhys-Evans, P.Harrington, K.J.Eccles, S.A. (2010). Tumour hypoxia and ALDH expression may contribute to reduced response to therapeutic agents in HNSCC cell lines, Presented at 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Berlin, GERMANY. EJC SUPPLEMENTS, Vol.8 (7), pp.102-1.

Nutting, C.Harrington, K.Rogers, S.Sydenham, M.Hern, R.A.Hall, E. (2010). Results of a Phase III Multi-centre Randomised Controlled Trial of Intensity Modulated (IMRT) vs Conventional Radiotherapy (RT) in Head and Neck Cancer (PARSPORT ISRCTN48243537, CRUK/03/005), CLINICAL ONCOLOGY, Vol.22 (10), pp.899-1.

Powell, C.Partridge, M.Riddell, A.Schmidt, M.Cook, G.Borri, M.Nutting, C.Harrington, K.Newbold, K. (2010). THE ROLE OF FUNCTIONAL IMAGING IN CHARACTERISING RADIOTHERAPY TARGET VOLUMES AND DISEASE RESPONSE IN PATIENTS UNDERGOING CHEMORADIATION FOR HEAD AND NECK CANCER (HNC), RADIOTHERAPY AND ONCOLOGY, Vol.96, p.S390.

Miah, A.Newbold, K.Harrington, K.Nutting, C.Bedford, J. (2010). VOLUMETRIC MODULATED ARC THERAPY (VMAT) CAN IMPROVE TARGET VOLUME COVERAGE WITHOUT INCREASING DOSE TO CRITICAL STRUCTURES IN LOW RISK SINONASAL CANCERS, RADIOTHERAPY AND ONCOLOGY, Vol.96, pp.S509-S510.

Buettner, F.Gulliford, S.Webb, S.Partridge, M.Miah, A.B.Harrington, K.J.Nutting, C.M. (2010). Using a Bayesian Feature-selection Algorithm to Identify Dose-response Models Based on the Shape of the 3D Dose-distribution: An Example from a Head-and-neck Cancer Trial., ICMLA, , pp.740-745.

Bhide, S.A.Gulliford, S.A'Hern, R.Hall, E.Newbold, K.Harrington, K.Nutting, C. (2009). Quantitative Estimates of the Effects of Concomitant Chemotherapy on Acute Dysphagia in Patients Receiving Radical Treatment for Head and Neck Cancer, Presented at 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, IL. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, Vol.75 (3), pp.S612-1.

Nutting, C.A'Hern, R.Rogers, M.S.Sydenham, M.A.Adab, F.Harrington, K.Jefferies, S.Scrase, C.Yap, B.K.Hall, E. (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005), Presented at 15th ECCO/34th ESMO Multidisciplinary Congress, Berlin, GERMANY. EJC SUPPLEMENTS, Vol.7 (3), pp.8-1.